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Abstract 
The purpose of this thesis was to examine the longitudinal associations between body mass 
and depressive symptoms as adolescents transition into young adults, using secondary data 
analysis of the National Longitudinal Survey of Children and Youth. Adolescents (N = 
1,895) were followed across five ages, between ages 17 and 25. Body mass and depressive 
symptoms were self-reported at each age. Latent growth modelling was used for all analyses. 
Results showed that the trajectory of body mass increased over time, while the trajectory of 
depressive symptoms decreased over time, for both males and females. Adolescent females 
with higher initial body mass levels reported a slower decrease in depressive symptoms over 
time. Conversely, adolescent males with higher initial depressive symptoms reported a 
slower increase in body mass over time. Public health implications, future research 
initiatives, and conclusions are further discussed. 
 
Keywords 
Depressive symptoms, Body mass, Adolescence, Young adulthood, Developmental, 
Longitudinal, Growth Curve Modelling, Trajectories.  
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Chapter 1  
1 Background 
1.1 Body mass and depressive symptoms 
Among Canadian adolescents, both body mass and depressive symptoms have 
become increasingly significant public health concerns, as respective increases in these 
health outcomes place individuals at heightened risk of becoming overweight/obese and 
developing clinically significant depressive symptoms1 (Roberts, Lewinsohn, and Seeley, 
1991; Shields, 2006). Over the past three and a half decades, the prevalence of obesity 
has increased substantially in economically developed countries such as Canada 
(Lobstein, Baur, & Uauy, 2004). Particularly alarming is the rate of increase in 
adolescents and young adults. According to a nationally representative sample of 
Canadians, the obesity rate for adolescents aged 12-17 tripled between 1978 and 2004, 
from 3% to 9% (Shields, 2006). Although obesity is increasing in all age groups, young 
adults aged 18 to 29 are experiencing the highest rate of increase (Mokdad, Serdula, 
Dietz, et al., 1999). In Canada, the obesity rate for 25-34 year olds more than doubled 
from 1978 (9%) to 2004 (21%; Tjepkema, 2006). In a 2007 national survey of Canadians, 
6.4% of 18-19 year olds and 11% of 20-24 year olds were classified as obese (Shields, 
2008). The obesity rate for 18-29 year olds in the United States increased from 7.1% in 
1991 to 12.1% in 1998 (Mokdad et al., 1999). The increased prevalence of obesity in 
adolescence and young adulthood has been linked to the concurrent rise of many physical 
health problems normally associated with adults, including type 2 diabetes, 
                                                 
1
 Note, there is a difference between depressive symptoms and clinically significant depressive symptoms. 
Depressive symptoms are defined as any one or more symptoms identified in validated depressive 
symptom scale(s) (e.g., decreased enjoyment of pleasurable activities, low self-esteem, hopelessness, 
apathy, difficulty sleeping, etc.,), with higher scores (across the entire continuum of scores) indicating 
higher depressive symptoms (Radloff, 1977). Clinically significant depressive symptoms are defined as an 
established cut point in depressive symptom scales used to distinguish a sufficient amount of depressive 
symptomology to closely resemble clinically depressed patients in treatment (Berkman, Berkman, Kasl, et 
al., 1986). For example, using the Center for Epidemiological Studies- Depression Scale (CES-D; Radloff, 
1977), a cut point of greater than or equal to 22 for adolescent males and 24 for adolescent females is 
suggested to identify cases of Diagnostic and Statistical Manual III- Revised (DSM-III-R) major depression 
and dysthymia (Roberts, Lewinsohn, and Seeley, 1991). 
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cardiovascular disease, hypertension and stroke, and certain forms of cancer (World 
Health Organization [WHO], 2003).  
In addition to increases in body mass, depressive symptoms during adolescence 
are also common (Birmaher, Ryan, Williamson, et al., 1996). In fact, late adolescence has 
been reported to be the period of the lifespan with the greatest experience of depressive 
symptoms (Wight, Sepúlveda, & Anashensel, 2004). Following a peak at about age 16 to 
17 years of age, depressive symptoms tend to gradually decline into young adulthood 
(Ge, Natsuaki, & Conger, 2006; Wight et al., 2004). Depressive symptoms during 
adolescence and young adulthood include decreased enjoyment of pleasurable activities, 
low self-esteem, hopelessness, apathy, and difficulty sleeping (Radloff, 1977). At 
particular cutoffs, these symptoms have been shown to predict the development of major 
depression disorder (Georgiades, Lewinsohn, Monroe, & Seeley, 2006), which in turn has 
been associated with increased risk of coronary heart disease, myocardial infarction, and 
mortality (Birmaher, Brent, Bernet, et al., 2007; Birmaher, Williamson, Dahl, et al., 2004; 
Brent, 2006; Faith, Matz, & Jorge, 2002; Williamson, Birmaher, Brent, et al., 2000). 
1.2 Adolescence and young adulthood 
Keeping these particular health outcomes in mind, there has recently been 
growing awareness of the importance of the life course perspective in public health 
research. Increasingly, evidence has shown that factors operating at special critical 
periods earlier in life may influence health at later periods in the life course (Osler, 2006). 
By utilizing a life course perspective, the influence of a risk factor in one stage of life can 
be examined as individuals proceed into the next phase of life (Merten, Wichrama, & 
Williams, 2008).  
Adolescence and young adulthood are both particularly important developmental 
periods to consider when examining the course and co-occurrence of both body mass and 
depressive symptoms. Adolescence is a sensitive period of development, during which 
the influence of positive or negative experiences may have a lasting effect throughout the 
lifespan (Bornstein, 1989). Developmental psychologists consider adolescence an 
important life-stage to study because of the critical changes that mark this period of 
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development, especially as a result of puberty (Dahl, 2004). More specifically, puberty is 
linked to physical changes in body size (Dahl, 2004), making adolescence a 
developmental period for increased weight, as well as the onset and persistence of obesity 
(Dietz, 1994). In addition to physical changes in body size, adolescence is also marked as 
a period of heightened emotions (Dahl, 2004). Because of this natural tendency toward 
high-intensity feelings, it is not surprising that there is an increase in the onset of 
internalizing problems, such as depressive symptoms, within this age group (Elliott, 
Huizinga, & Menard, 1989; Kandel & Davies, 1982). 
Young adulthood, on the other hand, is a developmental stage characterized by 
increased educational endeavours, establishing employment, and establishing and 
maintaining interpersonal and intimate relationships (Merten et al., 2008). Young 
adulthood marks the point in time where major transitional changes occur. For example, 
across the lifespan young adulthood is the period with the highest level of fertility, the 
highest marriage rates, the highest rates for leaving school, and the highest residential 
migration rates (Rindfuss, 1991). For the majority of young adults, major decisions and 
role changes occur in most areas of life and are occurring in a relatively short and 
overlapping period, making this time in the life course particularly dynamic (Rindfuss, 
1991). Individuals in this life stage have much more independence over important life 
choices, such as physical activity, dietary intake, and participation in healthy or unhealthy 
behaviors (e.g., binge drinking, smoking; Kemper, Post, Twisk, & van Mechelen, 1999), 
all of which affect physical health. With regards to mental health, young adults also 
acquire a significantly greater capacity for integrating thought and emotion, allowing for 
greater emotional regulation than they had as adolescents.  
In addition to period-specific changes that occur during adolescence and young 
adulthood, large and complex changes also occur as adolescents transition into young 
adults. Increases in body mass among adolescents and young adults in particular is a 
major health concern because overweight and obese conditions in these developmental 
stages tend to persist into adulthood (Whitaker, Wright, Pepe, Seidal, & Dietz, 1997). For 
example, researchers have reported that more than 70% of obese adolescents become 
obese adults (Guo, Roche, Chumlea, Gardner, & Siervogel, 1994). In addition, daily 
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physical activity tends to decrease from adolescence into young adulthood, whereas fat 
mass gradually increases (Kemper et al., 1999). In a longitudinal study, Kemper and 
colleagues (1999), reported that while less than 10% of males were classified as obese at 
age 13-16, by the time these individuals were 32 years old, this percentage doubled to 
20%. For females, increases in obesity went from 10% at ages 12-16 to 30% at age 32. 
Overall, the increase in body mass as well as the decrease in depressive symptoms that 
occur as adolescents become young adults, illustrate that the transition from adolescence 
to young adulthood with respect to these health outcomes is an important developmental 
period on which to focus academic attention (Sampson & Mrazek, 2001). 
1.3 Objective and rationale 
While the links between body mass and physical health have been established, the 
same is not true for relations with psychological health indices such as depressive 
symptoms (Hill, 2005). Recently however, the high prevalence of obesity and depression 
has led researchers to examine potential associations between the two. Although there is 
some research on the cross-sectional relationship between body mass and depressive 
symptoms (Baumeister & Härter, 2007; Faith et al., 2002; John, Meyer, Hapke, Rumpf, 
& Schumann, 2004), it is still unclear how these two health outcomes interact over time 
(Faith, Butryn, Wadden et al., 2011; Liem, Sauer, Oldehinkel, & Stolk, 2008).  
In addition, there is no consistency in the literature regarding the role of sex on 
these associations, especially during the transition from adolescence to young adulthood. 
These are important research questions to address for two primary reasons. First, body 
mass and depressive symptoms are both dynamic developmental processes that change 
across the lifespan (Needham, Epel, Adler, & Kiefe, 2010), and thus should be examined 
prospectively within a developmental framework in order to identify important changes. 
Second, body mass (Shields, 2006) and depressive symptoms (Kuczmarski, Ogden, Guo, 
et al., 2002; Locke & Newcomb, 2001) are both differentially distributed based on sex, 
thus longitudinal associations between the two may drastically vary for males and 
females. 
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Studying how body mass and depressive symptoms independently change, as well 
as how they are associated over time, will aid in understanding the course and 
consequences of both health outcomes. Furthermore, an important research and public 
health question to address is whether there is a causal relation between both body mass 
and depressive symptoms in the transition from adolescence to young adulthood, and 
whether these associations are similar for males and females. In a recent review, Liem 
and colleagues (2008) suggested that identifying treatable predictors such as depressive 
symptoms could lead to better outcomes for preventing and treating overweight and 
obesity later in life. In similar respects, psychological issues may be preventable by 
addressing physical health and body weight issues early on. Understanding the sex 
differences in these associations may help determine when, and to whom, resources 
should be targeted at to effectively prevent negative health outcomes later in life. Overall, 
given the toll that both body mass and depressive symptoms have on an individual’s 
quality of life and functioning, as well as the persistence and lifecourse stability both tend 
to have into adulthood (Bradley, Houts, Nader, et al., 2008), it is important to explore the 
potential links between them and target public health prevention strategies to help 
mitigate future adverse health outcomes (Calamaro & Waite, 2009).  
With these public health implications in mind, the objective of this thesis is 
examine the longitudinal associations between body mass and depressive symptoms 
during the transition from adolescence to young adulthood, and to investigate if and how 
these associations differ for males and females. By examining the relationship between 
body mass and depressive symptoms over time, we can determine whether longitudinal 
associations exist, as well as whether one health outcome better predicts the other. As 
previously mentioned, understanding the longitudinal associations between body mass 
and depressive symptoms may be an important step in identifying risk factors to target in 
prevention strategies aimed at increasing the physical and psychological well-being of 
adolescents and young adults (Clark, Haines, Head, et al., 2007). 
Few prospective studies have effectively evaluated this research question, and 
even fewer have focused on the developmentally important transition from adolescence 
to young adulthood. That is, while associations in adulthood have been heavily 
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researched (Bjerkeset, Romundstad, Evans, et al., 2008; Forman-Hoffman, Yankey, 
Hillis, Wallace, & Wolinsky, 2007; Gariepy, Wang, Lesage, & Schmitz, 2010; Needham 
et al., 2010; Roberts, Deleger, Strawbridge, & Kaplan, 2003), very little is known about 
the effect weight status has on the decrease in depressive symptoms across late 
adolescence and young adulthood, as well as the effect depressive symptoms have on the 
increase in weight across late adolescence and young adulthood. Thus, there is a need for 
well-formulated longitudinal research to examine the predictive direction of these 
associations across these developmental periods. 
The rest of this thesis will be organized in the following order: groups of 
theoretical models accounting for the prospective association between body mass and 
depressive symptoms, longitudinal research on the association between body mass and 
depressive symptoms, current plan of study, methods, results, and discussion. First, two 
major groups of theoretical models accounting for the prospective association between 
body mass and depressive symptoms will be presented with a focus on the adolescent and 
young adulthood developmental periods. Next, a literature review covering longitudinal 
research that has assessed the directions of association between body mass and depressive 
symptoms will be presented, as well as a summary of the limitations with current 
research in this area. Following this literature review and summary, a plan of study, along 
with specific objectives and hypotheses will be presented. Next, methodological topics 
covering the data source, variables used, and analyses will be discussed. Finally, the 
results will be presented, along with a discussion of findings and recommendations for 
future research. Important sex differences in the association between body mass and 
depressive symptoms will be highlighted throughout all sections. 
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Chapter 2  
2 Literature review 
2.1 Theoretical models accounting for the prospective 
association between body mass and depressive 
symptoms 
The purpose of this literature review is to examine the empirical evidence 
assessing the direction of association between body mass and depressive symptoms in 
adolescents and young adults. There are two major groups of theoretical models that 
explain the prospective association between body mass and depressive symptoms. The 
first group describes how increases in body mass may lead to increases in depressive 
symptoms over time. The second group describes how increases in depressive symptoms 
may lead to increases in body mass over time. Each of these models will be explained in 
detail below.  
2.1.1 Body mass affecting depressive symptoms 
There are many possible causal pathways, both psychologically and physically, 
that may lead adolescents and young adults with higher body mass to develop increases 
in depressive symptoms over time. These include the internalization of biased attitudes 
towards weight, weight-teasing, neurobiological causal pathways, and functional 
impairment. Each of these causal pathways will be explained in greater detail below. 
2.1.1.1 Internalization of biased attitudes 
According to the reflected self-appraisal hypothesis, an individual’s self-concept 
(i.e., his/her internalized view of himself/herself) is socially constructed through self-
appraisals and the judgments of others (Hayes & Ross, 1986; Ross, 1994). According to 
the social comparison theory, individuals engage in a continuous process whereby they 
compare themselves to people with whom they believe possess desirable traits (Festinger, 
1954). Thus, the thoughts and feelings individuals have about their body are constantly 
affected by social influences and the comparisons they make with others.  
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Since overweight status is perceived as a less attractive and more stigmatizing 
characteristic in Western cultures (Hill, 2005), individuals with higher body mass may 
internalize the negative attitudes of society towards their weight, resulting in lower self-
esteem and higher psychological distress (Ross, 1994). Studies on stereotyping have 
shown that obese individuals are viewed as being undisciplined, inactive, and 
unappealing (Hill, 2005). These stereotypes may be especially prominent during 
adolescence (Bradley et al., 2008) given the dramatic changes in cognitive functioning 
and physical development. In fact, these negative views tend to be held by people who 
are younger (Hill, 2005), placing heavier adolescents and young adults at a higher risk of 
being stereotyped by their peers. Thus, body mass may affect depressive symptoms 
through an internalization of biased attitudes from peer, family, and society towards the 
individual. 
Internalization of biased attitudes may be more prominent in females compared to 
males (Wadden & Stunkard, 1987), especially during adolescence and young adulthood. 
For adolescent boys, most of the weight gain as a result of puberty is explained by 
increases in muscle tissue, whereas weight gain for adolescent girls is mostly explained 
by significant fat mass deposition in the abdomen, buttock, and thigh regions (Tanner, 
1989). Overall, fat mass increase during this developmental period is significantly greater 
in females than males (Xie, Unger, Gallager, et al., 2010). Females also tend to place a 
great deal of subjective importance on their physical appearance (Wadden & Stunkard, 
1987). This increase in fat mass, paired with high levels of self-consciousness and 
embarrassment about the physical changes that accompany puberty, may place adolescent 
girls at a higher risk for the development of body image issues as well as increases in 
depressive symptoms over time (Wadden & Stunkard, 1987). 
2.1.1.2 Weight-teasing 
Weight teasing toward heavier individuals has been reported among health 
professionals, peers, and family members (Cash, 1995; Neumark-Sztainer, Story, & 
Faibisch, 1998). In fact, ‘fat-teasing’ is reported by one in seven adolescents (Hill, 2005). 
One study reported that, for females, weight teasing in middle adolescence was 
associated with lower self-esteem, lower body satisfaction, and marginally higher 
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depressive symptoms in young adulthood (Eisenberg, Neumark-Sztainer, Haines, & 
Wall, 2006). For males however, weight-teasing in middle adolescence did not 
prospectively predict increases in depressive symptoms during young adulthood, 
although it did predict lower body satisfaction. Thus, depressive symptoms may develop 
through poorer peer relationships and an increased dissatisfaction with appearance. The 
resulting poor peer relationships are also associated with poorer mental health (Hill, 
2005), making it more likely for adolescents to develop increases in depressive symptoms 
over time. Thus, increases in body mass may affect depressive symptoms through the 
stigma and social prejudices against these adolescents (Needham & Crosnoe, 2005).  
These associations may be stronger for females than for males. Compared to boys, 
girls are stigmatized significantly more often for their body mass, and they face more 
teasing, bullying and marginalization in social relationships (Tang-Peronard, & 
Heitmann, 2008). 
2.1.1.3 Neurobiological causal pathways 
In addition to social and psychological influences, physical health pathways exist 
that may also explain the association between increases in body mass and increases in 
depressive symptoms over time. For example, one such pathway is inflammation. 
Increases in body mass can be regarded as an inflammatory state since weight gain has 
been shown to activate inflammatory pathways (Emery, Fondow, Schneider, et al., 2007; 
Shoelson, Herrero, & Naaz, 2007). This inflammation, in turn, has been associated with 
an increase in depressive symptoms (Bremmer, Beekman, Deeg, et al., 2008; Milaneschi, 
Corsi, Pennix, et al., 2009; Vaccarino, Johnson, Sheps, et al., 2007). In extreme cases of 
increased body mass, obesity may involve hypothalamic-pituitary-adrenal (HPA) axis 
dysregulation (Pasquali, Vicennati, Cacciari, & Pagotto, 2006; Walker, 2001), which is 
known to be associated with depressive symptoms (Belanoff, Kalehzan, Sund, Fleming 
Ficek, & Schatzberg, 2001; Holsboer, 2000). Using yet another example, obesity may 
lead to increases in depressive symptoms through the associated increased risk of 
diabetes mellitus and increased insulin resistance (Lee, Lee, Ser, Chen, & Chen, 2008), 
both of which may result in brain alterations (Huber, 2008) and increased risk for 
depressive symptoms (Ajilore, Haroon, Kumaran, et al., 2007).  
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2.1.1.4 Functional impairment 
Functional impairment may also explain the association between higher body 
mass and depressive symptoms. Individuals with a high body mass who have greater 
difficulties with mobility and physical activity may be more likely to experience 
depressive symptoms over time (Bornstein, Schuppenies, Wong, & Licinio, 2006; Lago, 
Dieguez, Gomez-Reino, & Gualillo, 2007). For example, prospective studies have found 
an inverse association between physical activity and the development of depressive 
symptoms (Brown, Ford, Burton, Marshall, & Dobson, 2005; Camacho, Roberts, 
Lazarus, Kaplan, & Cohen, 1991; Farmer, Locke, Moscicki, et al., 1988; Lampinen, 
Heikkinen, Ruoppila, 2000; Paffenbarger, Lee, & Leung, 1994; Strawbridge, Deleger, 
Roberts, & Kaplan, 2002).  
2.1.1.5 Summary 
Overall, increases in body mass may affect depressive symptoms through many 
causal pathways, including an internalization of biased attitudes, weight-teasing, 
neurobiological causal pathways, and functional impairment. This prospective association 
may be stronger for female youth compared to male youth because females place greater 
importance on thinness as a popular ideal for feminine beauty (Wadden & Stunkard, 
1987). Girls are also more likely than boys to ruminate about and internalize negative 
feelings associated with their weight status (Fredrickson & Roberts, 1997). Finally, 
weight-teasing is more likely to occur for adolescent girls than boys (Tang-Peronard, & 
Heitmann, 2008). These factors may all translate to stronger prospective associations 
between higher body mass and increases in depressive symptoms for females compared 
to males. 
2.1.2 Depressive symptoms affecting body mass 
In addition to higher body mass affecting depressive symptoms over time, 
depressive symptoms may also lead to changes in body mass across adolescence and 
young adulthood. The causal pathways through which this prospective association may 
be explained includes neurobiological causal pathways and affect regulation, and 
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impaired sleep quality and physical inactivity. Each causal pathway will be explained in 
greater detail below. 
2.1.2.1 Neurobiological causal pathways and affect-regulation 
Depressive symptoms may lead to increases in body mass through various 
neurobiological causal pathways. For example, increased levels of cortisol are observed 
during periods of stress and depression, which can in turn induce abdominal obesity 
(Björntorp, 2001). Furthermore, serotonin dysregulation may characterize both 
depressive symptoms as well as the risk for obesity, such that individuals with 
disturbances in serotonin regulation may attempt to regulate their serotonin levels by 
consuming an excessive amount of carbohydrate-rich foods rich (Wurtman, Wurtmen, 
Mark, et al., 1985). Similarly, according to the affect-regulation model, individuals with 
increased depressive symptoms may be more likely to intake food excessively as an 
attempt to alleviate their negative affect (Liem et al., 2008). Coping mechanisms for 
depressive symptoms may also include consuming substances, such as cigarettes 
(Hooshmand, Willoughby, & Good, 2011), that are associated with weight gain 
(Goodman & Whitaker, 2002), as well as unhealthy eating (Laitinen, Power, Ek, Sovio, 
Järvelin, &  2002). In sum, these unhealthy behaviors may explain the association 
between depressive symptoms and weight gain (Greenfield, Rehm, & Rogers, 2002).  
2.1.2.2 Sleep quality and physical inactivity 
Impaired sleep quality is another potential causal pathway, as poor sleep quality is 
common in individuals with clinically significant depressive symptoms (Lauer, Wiegand, 
& Krieg, 1992; Riemann, Berger, & Voderholzer, 2001), and inadequate sleep is a risk 
factor for weight gain (Gangwisch, Malaspina, Boden-Albala, & Heymsfield, 2005). 
Depressive symptoms are also associated with lethargy, social withdrawal, and physical 
inactivity (Faith et al., 2011), and could therefore lead to weight gain; although, many 
authors report that adjusting for physical activity did not change the positive associations 
they initially found between depressive symptoms and body mass (Goodman & 
Whitaker, 2002; Needham & Crosnoe, 2005). 
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2.1.2.3 Summary 
Overall, depressive symptoms may affect weight gain through a variety of causal 
pathways, including neurobiological causal pathways and affect-regulation, and impaired 
sleep quality and physical inactivity. In contrast to the sex differences for the prospective 
associations between body mass and subsequent depressive symptoms, there is no 
theoretical rationale that prospective associations between depressive symptoms and 
subsequent increases in body mass may be stronger for females compared to males.  
2.2 Longitudinal research on the association between body 
mass and depressive symptoms 
Given this understanding of the groups of theoretical models, the longitudinal 
research assessing these associations will be examined next. The three main objectives of 
this section are to: 1) present a summary of all studies that investigated this research 
question; 2) highlight the conceptual, methodological, and analytical differences among 
studies that may contribute to the disparity in the current state of literature; and 3) 
identify the major limitations of previous research that will be addressed in the present 
study. 
Several exclusion criteria were applied when selecting studies to present in the 
literature review. First, since population-based associations examining change are of 
interest, the following literature review excludes clinical studies and studies that used 
clinical samples. Second, since depressive symptoms are of primary interest in the current 
study, the literature review excludes studies that used a diagnosis of depression. Third, 
only longitudinal studies in which the same participants were followed for two or more 
cycles of data collection will be examined, and studies that did not measure changing 
levels in the outcome of interest will be excluded (although these studies, when 
appropriate, are included in the Appendix, for more comprehensive coverage of the 
literature). Finally, in order to fully capture research on adolescents and/or young adults, 
the present literature review focuses solely on studies in which participants were younger 
than 30 years of age at the first cycle of data collection and older than 12 years of age at 
the last cycle of data collection (Rindfuss, 1991).  
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The following section will be divided into several component sections. Studies 
will first be organized into the direction of association they aimed to assess (i.e., body 
mass affecting depressive symptoms, and vice versa). Studies within each direction of 
association will be further organized into two subgroups: those that examined change 
across two points, and those that examined change across more than two points by using 
statistical techniques for longitudinal data (e.g., survival analysis, growth curve 
modeling). Summaries of research studies will then be presented in order to highlight the 
current disparities in the literature and provide reasoning, where possible, to explain these 
disparities. Following this literature review and summary, an overall rationale and 
objective for the direction of research in this area will be presented, as well as the 
limitations of past research that have prevented valid conclusions to be drawn concerning 
the direction of association between body mass and depressive symptoms. This section 
will conclude with a proposed model for examining the direction of these associations 
over time within the adolescent and young adult developmental periods. 
Before describing studies, it is important to recognize that there have been vast 
differences in how depressive symptoms have been operationalized and measured in 
previous research. Depressive symptoms have been measured using a wide array of 
symptom scales, including the Center for Epidemiological Studies- Depression Scale 
(CESD-D; Radloff, 1977), the Children’s Depression Inventory (CDI; Kovacs & Beck, 
1977), the Hopkins Symptom Checklist (HSCL; Derogatis, Lipman, Rickels, Uhlenhuth, 
& Covi, 2007), the Mood and Feeling Questionnaire (MFQ; Angold, Costello, Messer, et 
al., 1995), and Minnesota Multiphasic Inventory- Obvious Depression Scale (MMPI-
ODS; Greene, 1991).  In addition to the differences in scales used across studies, there 
were also several different versions of the same scale used across studies. With respect to 
the CES-D for example, different studies have utilized the CES-D-5 (Xie et al., 2010), the 
CES-D-9 (Merten et al., 2008), the CES-D-10 (Ball, Burton, & Brown, 2009), and the 
Modified CES-D-18 (Goodman & Whitaker, 2002). 
In addition, while some studies measured depressive symptoms using a 
continuous measure of the scale (Boutelle, Hannan, Fulkerson, Crow, & Stice, 2010; 
Franko, Striegel-Moore, Thompson, Schreiber, & Daniels, 2005; Merten et al., 2008; 
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Pine, Cohen, Brook, & Coplan, 1997; Stice, Presnell, Shaw, & Rohde, 2005; Tanofsky-
Kraff, Cohen, Yanovski, et al., 2006; Xie et al., 2010), others used cutoffs to identify 
clinically significant depressive symptoms (Ball et al., 2009; Clark et al., 2007; Goodman 
& Whitaker, 2002; Jansen, van de Looij-Jansen, de Wilde, & Brug, 2008; Rhew, 
Richardson, Lymp, et al., 2008), or both (Anderson, Murray, Johnson, et al., 2011; 
Barefoot, Heitmann, Helms, et al., 1998). All of these different operationalizations and 
measurements of depressive symptoms will be included for the purposes of presenting a 
comprehensive literature review, as well as to demonstrate the variability that currently 
exists across studies.  
2.2.1 Body mass affecting depressive symptoms 
Several studies have investigated whether increases in body mass affect 
subsequent depressive symptoms in adolescents and young adults. These studies are 
summarized below, as well as presented in greater detail in the Appendix. Studies are 
first organized into whether they measured change in depressive symptoms across two 
time points or more than two time points, then further organized into whether they 
reported a prospective association or not.  
2.2.1.1 Measuring change in depressive symptoms across two 
time points 
 The majority of studies have measured change across two time points to estimate 
the effect of body mass on subsequent depressive symptoms, controlling for prior levels 
of depressive symptoms and other covariates. The following four studies reported 
significant associations. First, Anderson and colleagues examined these associations in a 
cohort of adolescent females from public schools across the USA at two time points: 
grades six and eight (Anderson et al., 2011). The authors operationalized clinically 
significant depressive symptoms as a CES-D score of 24 and over, and categorized BMI 
into obese and non-obese using the Center for Disease Control (CDC) reference guide. 
The authors found a significant interaction between race and body mass, such that obesity 
status predicted subsequent clinically significant depressive symptoms only for White 
females. Associations were not significant for Hispanics, or for non-Hispanic Blacks. The 
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authors reported consistent findings when they repeated their analyses with depressive 
symptoms (using continuous CES-D scores) and body mass (using continuous BMI z-
scores).  
Ball and colleagues examined these associations in a cohort of young women in 
Australia who were 22-27 years old at baseline, and re-examined them three years later 
(Ball et al., 2009). The authors operationalized clinically significant depressive symptoms 
as a CES-D-10 score of 10 or more, and used the World Health Organization (WHO) 
classifications to categorize BMI (i.e., into underweight, overweight, normal weight, and 
obese categories). They found that overweight and obese females, compared with normal 
weight females, had a greater risk for clinically significant depressive symptoms at 
follow-up.  
 Using a nationally representative cohort from the United States, Merten and 
colleagues (2008) examined whether adolescent obesity at baseline was associated with 
increases in depressive symptoms six years later. The authors used continuous scores 
from the CES-D-9 as a measure of depressive symptoms, and categorized BMI into obese 
and not obese groups using the CDC reference guide. They reported a significant sex 
interaction, such that obesity for female adolescents, but not for male adolescents, was 
associated with higher depressive symptoms in young adulthood.  
Xie and colleagues (2010) used multiple group structural equation models to 
compare associations of obese status on subsequent depressive symptoms in a community 
sample of Asian and Hispanic middle school students in Los Angeles followed over one 
year. The authors used continuous scores from the CES-D-5 as a measure of depressive 
symptoms, and categorized BMI into overweight and not overweight groups using the 
CDC reference guide. They examined associations separately for males and females, for 
Asians and Hispanics, and for accultured and not accultured adolescents. They found that 
Asian males who were overweight at baseline had higher depressive symptoms at follow-
up than non-overweight Asian males. Also, males with low acculturation who were 
overweight at baseline had higher subsequent depressive symptoms compared to their not 
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overweight counterparts. The authors did not find any other significant associations (i.e., 
for girls, high accultured boys, or Hispanic boys). 
Only three studies that measured change in depressive symptoms across two time 
points did not report any significant findings. First, Clark and colleagues (2006) 
examined associations in a representative sample of adolescents (ages 11-14; re-
examined two years later) attending schools in East London. The authors identified 
clinically significant depressive symptoms as a score of eight or higher, using the Short 
Mood and Feeling Questionnaire (SMFQ; Angold et al., 1995), and used the United 
Kingdom reference curve classifications to categorize BMI into overweight (i.e., having a 
BMI greater than the 85th percentile), and obese (i.e., having a BMI greater than the 95th 
percentile). They found that neither overweight nor obese status predicted subsequent 
clinically significant depressive symptoms.  
Using a nationally representative cohort of US adolescents, Goodman and 
Whitaker (2002) examined the association between obesity in 7th-12th grade adolescents 
and clinically significant depressive symptoms one year later. The authors categorized 
clinically significant depressive symptoms as a Modified CES-D-18 score of 24 or more 
for females, and 22 or more for males, and used the CDC reference classifications for 
classifying BMI into obese and not obese categories. They found that being obese at 
baseline did not predict clinically significant depressive symptoms at follow-up.  
Rhew and colleagues examined whether overweight status in sixth grade 
predicted depressive symptoms one year later in a cohort of middle school students in 
Seattle, Washington (Rhew et al., 2008). The authors examined continuous log-
transformed depressive symptoms, measured using the MFQ (Angold et al., 1995), and 
categorized BMI into obese, overweight, and not overweight groups using CDC reference 
guides. They found that neither overweight nor obese status at baseline predicted 
depressive symptom scores at follow-up. 
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2.2.1.2 Measuring change in depressive symptoms using more 
than two time points 
Only one study used more complex longitudinal analyses in order to examine 
changes across more than two time points. Using repeated measures multivariate logistic 
regression over four annual cycles of data, Boutelle and colleagues examined the 
influence of overweight or obesity status the previous year on depressive symptoms the 
subsequent year, in adolescent females from public and private schools in Austin, Texas 
(Boutelle et al., 2010). The authors examined continuous depressive symptoms using an 
average of past year severity ratings for each symptom in the Schedule for Affective 
Disorders and Schizophrenia for School-Age Children (K-SADS; Chambers, Puig-
Antich, Hirsch, et al., 1985). Response options for each symptom ranged from 1 (not at 
all) to 4 (severe). BMI was categorized into obese, overweight, and not overweight 
groups using CDC reference guides. The authors reported a significant positive effect of 
obesity (but not overweight) on subsequent depressive symptoms.  
2.2.1.3 Summary of studies examining body mass affecting 
depressive symptoms 
In summary, these studies all aimed to investigate the theoretical framework that 
body mass leads to increases in depressive symptoms through the previously mentioned 
causal pathways (i.e., internalization of biased attitudes, weight-teasing, neurobiological 
causal pathways, and functional impairment). Of the eight studies reviewed, almost half 
did not report finding any sort of an association between baseline body mass and 
subsequent depressive symptoms. This discrepancy in research findings highlights the 
high level of inconsistency in research. One explanation for this inconsistency may be 
that inconsistent findings reflect an inconsistent phenomenon- that is, that body mass may 
predict depressive symptoms for some individuals but not others (Friedman & Brownell, 
1995). Although this may be the case, it is difficult to make this conclusion because the 
high level of variation among current studies makes cross-study comparisons 
challenging. 
These variations occur at the conceptual, methodological, and analytical levels, 
and may explain a great deal of the disparity in results for studies investigating body 
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mass as a predictor of subsequent depressive symptoms. Conceptual differences across 
studies exist in terms of the developmental periods studied, the operationalization of body 
mass and body mass comparison groups, the operationalization of depressive symptoms, 
and differences in the populations studied.  
With respect to the first conceptual variation, the majority of studies did not 
examine the developmental transition from adolescence to young adulthood, but instead 
focused solely on changes within adolescence (Anderson et al., 2011; Boutelle et al., 
2010; Clark et al., 2007; Rhew et al., 2008; Xie et al., 2010), or young adulthood (Ball et 
al., 2009). Although all studies operationalized body mass using categorizations, one 
study used a continuous measure of BMI in addition to categorization (Anderson et al., 
2011).  
There were also large variations among studies in operationalizing body mass 
comparison groups. For example, some studies compared obese adolescents to not obese 
adolescents, where the not obese group included individuals classified as overweight, 
normal weight, or underweight (Anderson et al., 2011; Goodman & Whitaker, 2002; 
Merten et al., 2008). Other studies compared obese and/or overweight groups to not 
overweight groups, where the not overweight group included individuals classified as 
either normal weight or underweight (Boutelle et al., 2010; Clark et al., 2007; Rhew et 
al., 2008; Xie et al., 2010). Of note, only one study compared obese, overweight, and 
underweight groups separately with normal weight groups (Ball et al., 2009). 
As previously mentioned, some studies operationalized depressive symptoms into 
categories by establishing clinically significant cutoffs from scaled continuous measures 
(Ball et al., 2009; Clark et al., 2007; Goodman & Whitaker, 2002). Other studies, 
however, operationalized depressive symptoms as a continuous scale, with higher scores 
indicating more depressive symptoms (Boutelle et al., 2010; Merten et al., 2008; Rhew et 
al., 2008; Xie et al., 2010). One study used both a continuous and categorized 
operationalization of depressive symptoms (Anderson et al., 2011).  
Studies also differed in the composition of the populations they examined. While 
most studies sampled both males and females (Clark et al., 2007; Goodman & Whitaker, 
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2002; Merten et al., 2008; Rhew et al., 2008; Xie et al., 2010), some sampled females 
only (Anderson et al., 2011; Ball et al., 2009; Boutelle et al., 2010). Also, some studies 
used at-risk samples (Rhew et al., 2008), samples with one predominant race/ethnicity 
(Xie et al., 2010), or samples from outside of North America (Ball et al., 2009; Clark et 
al., 2007). 
Methodologically, there are large variations among the length of intervals, source 
of height and weight measurements, reference tools for establishing body mass cutoffs, 
and tools for measuring depressive symptoms. In particular, studies differed on whether 
they examined associations over annual (Boutelle et al., 2010; Goodman et al., 2002; 
Rhew et al., 2008; Xie et al., 2010), biennial (Anderson et al., 2011; Clark et al., 2007), 
or longer (Ball et al., 2009; Merten et al., 2008) intervals. Additionally, when calculating 
BMI, some studies used measured height and weight (Anderson et al., 2011; Boutelle et 
al., 2010; Clark et al., 2007; Xie et al., 2010), while others used self-reported height and 
weight (Ball et al., 2009; Goodman & Whitaker, 2002; Merten et al., 2008). 
With regards to reference tools for establishing body mass cutoffs, studies ranged 
in their use of categorizations based on CDC (Anderson et al., 2011; Boutelle et al., 2010; 
Goodman & Whitaker, 2002; Merten et al., 2008; Rhew et al., 2008; Xie et al., 2010), 
WHO (Ball et al., 2009), or other reference guides (Clark et al., 2007). Finally, every 
study used a slightly different measurement tool to assess depressive symptoms, ranging 
from K-SADS (Boutelle et al., 2010), MFQ (Rhew et al., 2008) or SMFQ (Clark et al., 
2007), and different versions of the CES-D (Anderson et al., 2011; Ball et al., 2009; 
Merten et al., 2008; Goodman & Whitaker, 2002; Xie et al., 2010). 
Analytically, studies varied in the number of measurement points used for 
analyses. While one study examined associations over three or more cycles (Boutelle et 
al., 2010), the majority of research in this area focused on assessing only two points 
(Anderson et al., 2011; Ball et al., 2009; Clark et al., 2007; Goodman & Whitaker, 2002; 
Merten et al., 2008; Rhew et al., 2008; Xie et al., 2010). Studies also varied in the 
statistical techniques they used to assess whether body mass predicted subsequent 
depressive symptoms, with some using logistic regression techniques (Ball et al., 2009; 
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Clark et al., 2007; Goodman & Whitaker, 2002), and others using linear regression 
techniques (Boutelle et al., 2010; Merten et al., 2008; Rhew et al., 2008; Xie et al., 2010).  
Finally, there have been large discrepancies between each study with respect to 
the covariates controlled for during analyses. The table in the Appendix illustrates this 
discrepancy by listing all covariates considered for each study. Entering a different set of 
covariates into a model could impact results by changing the estimated effect that body 
mass has on subsequent depressive symptoms. Without this consistency in covariates 
used, cross-study comparisons are made much more difficult.  
Certain patterns are evident with respect to these conceptual, methodological, and 
analytical variations among studies, in which certain types of studies may be more likely 
to report an effect than others. Restricting the literature review to only those two studies 
that examined, to some extent, the transition between adolescence and young adulthood, 
both studies investigated associations in both males and females, and reported 
nonsignificant associations for males (Goodman & Whitaker, 2002; Merten et al., 2008).  
When focusing on adolescents as they transition to young adulthood, there is 
some evidence that body mass may be more predictive of moderate increases in 
depressive symptoms, as opposed to being predictive of clinically significant depressive 
symptoms. For example, Goodman and Whitaker (2002) used a CES-D cutoff for 
predicting clinically significant depressive symptoms in adolescents (Roberts et al., 
1991), and reported that 12-19 year-olds who were obese at baseline did not have an 
increased risk of clinically significant depressive symptoms when measured one year 
later. On the other hand, using a continuous scale for depressive symptoms, Merten and 
colleagues (2008) examined the association between obesity at age 12-18 and depressive 
symptoms five years later and found that, among females, obesity in adolescence was 
associated with higher depressive symptom scores during young adulthood.  
From these patterns, there is some evidence that, for adolescents transitioning to 
young adulthood, associations between body mass and subsequent depressive symptoms 
are nonsignificant for males; and also that increases in body mass may lead to higher 
levels of depressive symptoms, but not necessarily clinically significant depressive 
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symptoms.  However, it is still difficult to compare findings across studies with two or 
even three similarities, as results may be confounded by the many other study differences 
(i.e., operationalization of body mass comparison groups, populations examined, 
statistical techniques, and covariates modelled). Overall, although greater precision in 
conceptualization, methodology, and analytical techniques across studies would 
potentially translate to less variety in results, the vast differences in the design of 
previous studies makes cross-study comparisons difficult. 
2.2.2 Depressive symptoms affecting body mass 
Several studies have also investigated whether depressive symptoms affect 
subsequent increases in body weight in adolescents and young adults. These studies are 
summarized below, as well as presented in greater detail in the Appendix. Studies are 
first organized into whether they measured change in body mass across two time points 
or more than two time points, then further organized into whether they reported a 
prospective association or not. 
2.2.2.1 Measuring change in body mass with only two time points 
Several studies have measured change across two time points in order to estimate 
the influence of depressive symptoms on subsequent body mass, controlling for prior 
levels of body mass and other covariates. The following five studies reported significant 
associations. First, Anderson and colleagues (2011) examined these associations in a 
cohort of adolescent females from public schools across the USA at two time points: 
grades six and eight. The authors operationalized clinically significant depressive 
symptoms as a CES-D score of 24 and over, and categorized BMI into obese and non-
obese using the Center for Disease Control (CDC) reference guide. The authors found a 
significant interaction between depressive symptoms and race such that, having clinically 
significant depressive symptoms at sixth grade predicted subsequent obesity in White 
females, but not in Black or Hispanic females.  They also repeated their analyses using 
continuous BMI scores and continuous depressive symptom scores and found similar 
results. 
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Using a nationally representative cohort of USA adolescents, Goodman and 
Whitaker (2002) examined the association between clinically significant depressive 
symptoms in 7th-12th grade adolescents and obesity one year later. The authors 
categorized clinically significant depressive symptoms as a Modified CES-D-18 score of 
24 or more for females, and 22 or more for males, and used the CDC reference 
classifications for classifying BMI into obese and not obese categories. The authors 
found that those who had clinically significant depressive symptoms at baseline had a 
higher risk of obesity at follow-up, compared to those who did not have clinically 
significant depressive symptoms at baseline.  
Franko et al. (2005) used two community-based cohorts of Black and White 
females from three US states to examine the influence of depressive symptoms (using 
continuous CES-D scores) on subsequent body mass. Body mass was analyzed as both a 
continuous and categorical variable (i.e., categorized into obese and not obese categories, 
using CDC reference guidelines). The first cohort was examined at age 16 and again at 
age 21; the second cohort was examined at age 18 and again at age 21. The authors 
reported that higher depressive symptoms at either age 16 or 18 predicted an increased 
risk of obesity at age 21. They also found a similar pattern of results when body mass was 
examined as a continuous variable, such that higher depressive symptoms at either age 16 
or 18 predicted an increase in body mass at age 21. 
Barefoot and colleagues examined associations between depressive symptoms and 
body mass in a cohort of North Carolina university students aged 16-25 at baseline, and 
again 23 years later (1998). Depressive symptoms were analyzed as both a continuous 
and categorical variable. As a categorical variable, the authors defined a high level of 
depressive symptoms as a Minnesota Multiphasic Inventory- Obvious Depression Scale 
(MMPI-ODS; Greene, 1991) score of 11 or higher for males, and 13 or higher for 
females2.  The authors found a significant interaction between initial body mass and 
                                                 
2
 Note, the categorization of high level of depressive symptoms identified by the authors does not reflect a 
level of clinically significant depressive symptoms, but only identifies those with a relatively large number 
of depressive symptoms (Barefoot et al., 1998). 
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depressive symptoms on weight change, such that individuals with a high level of 
depressive symptoms who were initially lean gained less weight (i.e., less of a change in 
BMI between two time points) than individuals with a low level of depressive symptoms 
who were initially lean. Furthermore, individuals with a high level of depressive 
symptoms who were initially heavy gained more weight than individuals without a high 
level of depressive symptoms. The authors reported similar results when a continuous 
measure of depressive symptoms was used instead of a dichotomized cutoff.  
Fifth, Rhew et al., 2008 examined whether clinically significant depressive 
symptoms in sixth grade predicted body mass one year later in a cohort of middle school 
students in Seattle, Washington. The authors categorized clinically significant depressive 
symptoms as a MFQ score of 15 or higher for males, and 20 or higher for females, and 
used a continuous measure of self-reported BMI. They found a significant interaction 
between sex and depressive symptoms. Males with clinically significant depressive 
symptoms at baseline had lower subsequent body mass compared to males without 
clinically significant depressive symptoms. For females, clinically significant depressive 
symptoms at baseline did not predict subsequent body mass.  
Two studies that measured change in body mass across two time points did not 
report any significant findings. First, Stice et al. (2005) examined associations between 
depressive symptoms at 11-15 years and development of obesity over a four-year period 
in a sample of adolescent girls from schools across metropolitan southwestern USA. The 
authors examined continuous depressive symptoms using an average of severity ratings 
for each symptom in the K-SADS. BMI was categorized into obese and not obese groups 
using CDC reference guides. The authors found that depressive symptoms at baseline did 
not predict the onset of obesity over a four-year period. 
In another study, Jansen et al. (2008) examined associations between clinically 
significant depressive symptoms and subsequent overweight and obesity (using WHO 
classifications) in a cohort of youth from Rotterdam, ages 9-10 at baseline and 12-13 at 
follow-up. The authors categorized clinically significant depressive symptoms as a score 
of four or more using the Short Depression Questionnaire for Children (SDQC; Meier, 
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Mellenbergh, & de Wit, 1986), and used WHO classifications for categorizing BMI into 
not overweight, overweight, and obese categories. The authors found that clinically 
significant depressive symptoms at baseline did not predict overweight status or obese 
status three years later in this cohort of young adolescents.  
2.2.2.2 Measuring change in body mass using more than two time 
points 
Only one study testing the directional association between baseline depressive 
symptoms and subsequent body mass used more than two time points. Tanofsky-Kraff et 
al. (2006) used an average of 4.2 annual measurements of children from Maryland, USA, 
who were 6-12 years old at baseline, and applied mixed regression models with 
depressive symptoms as a fixed effect and the child as a random effect. The authors used 
CDI scores as a continuous measure of depressive symptoms, and used a dual-energy x-
ray absorptiometry (DEXA) continuous scale to measure fat mass and change in fat mass 
over time. The authors found that baseline depressive symptoms did not predict increases 
in body fat mass over the course of the study, and that interaction effects with sex were 
not statistically significant. 
2.2.2.3 Summary of studies examining depressive symptoms 
affecting body mass 
In summary, although all of these studies investigated the theoretical framework 
that depressive symptoms lead to increases in body mass through the previously 
mentioned causal pathways (i.e., neurobiological causal pathways and affect-regulation, 
and sleep quality and physical inactivity), most did not make any explicit mention of a 
driving theoretical framework (Barefoot et al., 1998; Franko et al., 2005; Goodman & 
Whitaker, 2002; Jansen et al., 2008; Rhew et al., 2008; Tanofsky-Kraff et al., 2006;). 
Overall, there is some evidence that initial depressive symptoms are prospectively 
associated with an increase in body mass in adolescents and young adults. On the other 
hand, almost one half of the studies testing the directional association from depressive 
symptoms to body mass reported null findings. There was also a great deal of 
inconsistency regarding whether or not differential prospective associations between 
depressive symptoms and subsequent body mass exist for males and females. Of the five 
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studies that assessed sex differences, only one found a different pattern of results for 
males and females such that associations were inversely significant for males (i.e., 
clinically significant depressive symptoms predicted lower subsequent BMI; Rhew et al., 
2008).  
As was the case above, the inconsistencies in results of studies assessing the 
direction of association from depressive symptoms to increases in body mass reflect a 
disparity in the conceptual, methodological, and analytical frameworks among studies. 
Conceptual differences across studies examining whether depressive symptoms predict 
increases in body mass are similar to those studies examining the opposite direction of 
association (i.e., body mass to depressive symptoms). Differences across studies exist on 
multiple levels in terms of developmental periods studied, operationalization of body 
mass, and differences in the populations studied. 
Only two studies examined the developmental transition from adolescence to 
young adulthood (Franko et al., 2005; Goodman & Whitaker, 2002). Instead, most 
studies focused solely on changes within adolescence (Anderson et al., 2011; Jansen et 
al., 2008; Rhew et al., 2008; Stice et al., 2005; Tanofsky-Kraff et al., 2006); or young 
adulthood (Barefoot et al., 1998).  
With regards to operationalizing body mass into categories, most studies used 
cutoffs to define overweight and/or obese status (Goodman & Whitaker, 2002; Jansen et 
al., 2008; Rhew et al., 2008; Stice et al., 2005). A few studies, however, operationalized 
body mass as a continuous scale of BMI (Barefoot et al., 1998; Tanofsky-Kraff et al., 
2006). One study used both a continuous and categorized operationalization of body mass 
(Anderson et al., 2011). 
Studies also differed in the populations they examined. While most studies 
sampled both males and females (Barefoot et al., 1998; Goodman & Whitaker, 2002; 
Jansen et al., 2008; Rhew et al., 2008; Tanofsky-Kraff et al., 2006), some sampled 
females only (Anderson et al., 2011; Franko et al., 2005; Stice et al., 2005). There were 
also some differences across studies in the composition of the population from which 
participants were sampled. For example, a few studies used at-risk samples (Rhew et al., 
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2008; Tanofsky-Kraff et al., 2006). Anderson and collegues (2011), as well as Goodman 
and Whitaker (2002) included only Hispanic, non-Hispanic Black, and non-Hispanic 
White adolescents in their studies. Franko and colleagues (2005), and Tanofsky-Kraff et 
al., (2006) only sampled Black or White participants from the United States. One study 
investigated associations in adolescents and young adults from the Netherlands (Jansen et 
al., 2008).  
Methodologically, there are large variations among the length of intervals, source 
of height and weight measurements, reference tools for establishing body mass cutoffs, 
and tools for measuring depressive symptoms. In terms of interval length, most studies 
examined associations over annual (Goodman & Whitaker, 2002; Rhew et al., 2008; 
Stice et al., 2005; Tanofsky-Kraff et al., 2006) or biennial (Anderson et al., 2011; Franko 
et al., 2005) cycles, whereas others used intervals between three and six years (Franko et 
al., 2005; Jansen et al., 2008) or much longer (Barefoot et al., 1998).  
When calculating BMI, most studies used measured height and weight (Anderson 
et al., 2011; Stice et al., 2005), while one used self-reported height and weight (Goodman 
& Whitaker, 2002). Of note, a few studies used inconsistent measurements between 
cycles (Barefoot et al., 1998; Franko et al., 2005; Jansen et al., 2008). That is, height and 
weight would be measured at one cycle and self-reported at another. One study used 
DEXA to directly measure fat mass (Tanofsky-Kraff et al., 2006). With regards to 
reference tools for establishing body mass cutoffs, almost all but one study (Jansen et al., 
2008) used categorizations based on CDC.  
Finally, almost every study used a slightly different measurement tool to assess 
depressive symptoms, including K-SADS (Stice et al., 2005), MFQ (Rhew et al., 2008), 
MMPI ODS (Barefoot et al., 1998), CDI (Tanofsky-Kraff et al., 2006), SDQC (Jansen et 
al., 2008), and different versions of the CES-D (Anderson et al., 2011; Franko et al., 
2005; Goodman & Whitaker, 2002). 
Analytically, studies varied in the number of measurement points used for 
analyses. While one study examined associations over four cycles (Tanofsky-Kraff et al., 
2006), the majority of research in this area focused on assessing only two points 
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(Anderson et al., 2011; Franko et al., 2005; Goodman & Whitaker, 2002; Jansen et al., 
2008; Rhew et al., 2008; Stice et al., 2005). Studies also varied in the statistical 
techniques they used to assess whether depressive symptoms predicted subsequent body 
mass, with some using logistic regression techniques (Goodman et al., 2002; Jansen et al., 
2008; Stice et al., 2005), and others using linear regression techniques (Barefoot et al., 
1998; Rhew et al., 2008; Tanofsky-Kraff et al., 2006). 
As was the case for studies examining the effect of body mass on subsequent 
depressive symptoms, studies examining this direction of association have also varied 
greatly in their use of covariates controlled for during analyses. The table in the 
Appendix illustrates this discrepancy by listing all covariates considered for each study. 
As mentioned above, inconsistencies in covariates used make cross-study comparisons 
much more difficult. 
Overall, there are potentially multiple combinations of differences across studies 
with respect to the operationalization of depressive symptoms and body mass, the 
populations studied, the number and length of intervals, the statistical technique for 
analyses, and the use of covariates that could drastically affect not only the findings of 
each study, but also the interpretation of the literature. For example, continuous BMI 
levels may be differentially associated with depressive symptoms than an obesity or 
overweight classification. Similarly, continuous depressive symptoms may predict body 
mass differentially than clinically significant depressive symptoms. Furthermore, 
differences in results may exist between males and females, across different races, or 
across samples selected from different parts of the world. Finally, entering a different set 
of covariates into a model could impact results by changing the estimated effect that 
depressive symptoms have on subsequent body mass. Overall, the multiple possibilities 
of study design makes comparisons difficult because it becomes impossible to tease out 
similarities among studies when there are yet so many levels of differences.  
As opposed to the findings from studies investigating the direction of association 
from body mass to depressive symptoms, previous research examining the direction of 
association from depressive symptoms to body mass had few discernable patterns in 
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results with regards to conceptual, methodological, and analytical differences. That is, 
because there were such few similarities and such great differences among studies, it was 
not possible to identify certain types of studies that were more likely to find an effect than 
others. One evident pattern was that, of the two studies that examined both males and 
females and did not report a significant effect (Jansen et al., 2008; Tanofsky-Kraff et al., 
2006), both controlled for sex in the analysis instead of testing whether results differed 
for males and females. Rhew and colleagues (2008) found that males clinically 
significant depressive symptoms at baseline had lower subsequent body mass, whereas 
females with clinically significant depressive symptoms at baseline had higher 
subsequent body mass. Thus, not accounting for this sex difference analytically may lead 
to null associations. 
Overall, there is some evidence that with respect to depressive symptoms 
predicting body mass, differential associations may exist between males and females. 
However, because of the complexity and amount of conceptual, methodological, and 
analytical differences among studies, it is difficult to conclusively compare findings. As 
previously mentioned, greater precision in the methodologies across studies would 
translate to less variety in results. However, the vast differences in the current state of 
literature on depressive symptoms predicting body mass make cross-study comparisons 
difficult. A major goal for research in this area should be to work towards greater 
consistency by addressing the major limitations of previous research and providing a 
strong justification for the operationalization of concepts, as well as the methodologies 
and analytical techniques used. 
2.2.3 Limitations in current literature 
In addition to the above-mentioned conceptual, methodological, and analytical 
differences among studies, there are several key within-study limitations that may also 
contribute to mixed findings in the literature. The major limitations of previous research 
are: lack of consistency in measuring body mass and depressive symptoms over cycles, 
failure to assess longitudinal change in outcomes, using only two waves of data, failure to 
examine reciprocal relationships, and finally, lack of transitional research examining the 
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adolescent to young adult developmental period. Problems with these key limitations are 
explained in detail below. These within-study limitations are also summarized in Table 1. 
Table 1: Within-study limitations of previous research. 
 
First author, year Inconsistent 
measurement 
tool for body 
mass and/or 
depressive 
symptoms 
Did not 
control for 
or exclude 
baseline 
dependent 
variable 
Two 
cycles 
Did not 
examine 
reciprocal 
relationship 
Did not 
examine 
adolescent 
to young 
adult 
transition 
       
Anderson, 2011 
  X  X 
Ball, 2008 
  X X X 
Bardone, 1998* 
 X X X  
Barefoot, 1998 X  X X X 
Boutelle, 2010 
   X X 
Clark, 2006 
  X X X 
Duarte, 2010* 
 X X X  
Franko, 2005 X  X X  
Goodman, 2002 
  X   
Goodwin, 2009* 
 X X X  
Herva, 2006* 
 X X X  
Jansen, 2008 X  X X X 
Merten, 2008 
  X X  
Pine, 1997* X X X X  
Rhew, 2008 
  X  X 
Stice, 2005 
   X  
Tanofsky-Kraff, 
2006    X X 
Xie, 2010 
    X X X 
      
Note. *Not included in literature review because does not measure 
change in outcome. 
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2.2.3.1 Inconsistency in measurement tools for body mass and/or 
depressive symptoms 
Many studies have used inconsistencies in the source of height and weight reports 
across cycles (Barefoot al., 1998; Franko et al., 2005; Jansen et al., 2008). For example, 
Franko and colleagues (2005) used self-reported height and weight to calculate 
participants BMI at the first cycle, but used measured height and weight during the 
subsequent cycle. Similarly, Jansen and colleagues (2008) and Barefoot and colleagues 
(1998) both used measured height and weight at baseline and self-reported height and 
weight at follow-up. Inconsistencies across cycles in the source of height and weight 
reports may bias results if sources are differentially accurate in their reports of height and 
weight (Goodman, Hinden, & Khandelwal, 2000).  
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2.2.3.2 Failure to assess longitudinal change in outcomes 
Many studies did not assess longitudinal change in outcomes because they failed 
to control for baseline levels of the dependent variable (Bardone, Moffitt, Caspi, et al., 
1998; Duarte, Sourander, Nikolakaros, et al., 2010; Goodwin, Sourander, Duarte, et al., 
2009; Herva, Laitinen, Miettunen, et al., 2006; Pine et al., 1997). As is the case with all 
longitudinal analyses, controlling for initial levels of an outcome ensures that models are 
predicting change over time instead of stability in the health outcome over time (Stice & 
Bearman, 2001). For example, past depressive symptoms are known to predict future 
depressive symptoms (Eaton, Shao, Nestadt et al., 2008), thus, failing to control for initial 
levels of depressive symptoms makes it difficult to model the effects of body mass on the 
development of depressive symptoms.  
2.2.3.3 Examining less than three cycles of data 
The third major limitation of previous research is that most studies measured 
these health outcomes across only two waves (Anderson et al., 2011; Ball et al., 2009; 
Barefoot et al., 1998; Clark et al., 2007; Franko et al., 2005; Goodman & Whitaker, 2002; 
Jansen et al., 2008; Merten et al., 2008; Rhew et al., 2008; Xie, et al., 2010). Although 
technically measuring change, these studies assess development poorly (Rogosa, Brandt, 
& Zimowski, 1982) because two-panel designs do not allow for examination of 
developmental trajectories, and thus may only be appropriate when the growth process is 
irrelevant or known to be linear (Duncan, Duncan, & Strycker, 2006). However, neither 
body mass nor depressive symptoms are linear processes during the transition between 
adolescence and young adulthood (Needham et al., 2010). Thus, measuring less than 
three waves of data does not take into account the growth process involved nor does it 
allow for the identification of curvilinear trajectories for either health outcome. 
2.2.3.4 Failure to examine reciprocal relationship 
The majority of longitudinal studies (Ball et al., 2009; Barefoot et al., 1998; 
Boutelle et al., 2010; Clark et al., 2007; Franko et al., 2005; Jansen et al., 2008; Merten et 
al., 2008; Stice et al., 2005; Tanofsky-Kraff et al., 2006; Xie et al., 2010) that test the 
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association between body mass and depressive symptoms have focused on measuring 
only one direction of the relationship (i.e., body mass predicting depressive symptoms, or 
vice versa). Statistically measuring one direction does not test whether there are 
reciprocal associations between body mass and depressive symptoms within the same 
sample. Investigating reciprocal relationships over time is important in order to examine 
whether the predictive relationship is unidirectional, or whether there are reciprocal 
effects where either construct may predict growth in the other (Needham, et al., 2010). 
These alternative mechanisms would have different implications for etiology, prevention, 
and treatment.  
2.2.3.5 Lack of adolescent to young adulthood transitional 
research 
Finally, many studies focus on young adult populations (Ball et al., 2009; 
Barefoot et al., 1998; Forman-Hoffman et al., 2007; McCarty, Kosterman, Mason, et al., 
2009; Needham et al., 2010; Roberts et al., 2003) or younger adolescents (Anderson et 
al., 2011; Boutelle et al., 2010; Clark et al. 2007; Jansen et al., 2008; Rhew et al., 2008; 
Tanofsky-Kraff et al., 2006; Xie et al., 2010). The association between body mass and 
depressive symptoms may be different for adolescents than for children or adults 
(Napolitano & Foster, 2008), and there is far less research on adolescents as they 
transition into young adults. Adolescence and young adulthood are critical periods of 
growth and maturation, and are associated with changes in diet, physical activity, 
sedentary behavior, as well as psychological health (Alberga, Sigal, Goldfield, 
Prud'homme, & Kenny, 2012). Thus, an understanding of the causal associations between 
mental and physical health during this transition is needed, and differentiating findings 
from earlier or later life stages is important for public health initiatives. 
Only four studies in the present literature review examined prospective 
associations as adolescent’s transition into young adults (Franko et al., 2005; Goodman & 
Whitaker, 2002; Merten et al., 2008; Stice et al, 2005). However, each of these studies 
present with limitations of their own, as identified in Table 1. For example, by only 
examining two data points, Merten and colleagues (2008) could not effectively examine 
the developmental growth in either health outcome. Also, having a six-year interval 
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between data points could potentially increase the chances of transitional life events 
confounding prospective associations. The second major limitation of the Merten and 
colleagues (2008) study is that they compared obese adolescents to not obese adolescents, 
such that the not obese group comprised of overweight, normal weight, or underweight 
adolescents. The mental health status of overweight and underweight adolescents may be 
systematically different from normal weight adolescents, and collapsing all three weight 
categories into a single comparison group may bias results if there are differences among 
these weight categories.  
In another example, the study by Franko and colleagues (2005) is limited in its 
ability to generalize to the population since the authors only sampled Black and White 
females. They also had inconsistent reporting sources for height and weight, where self-
reports were used at the first wave and measured height and weight at the second wave. 
Therefore, the increase in body mass at the second wave may reflect a true consistency in 
body mass that was not captured in the first wave because adolescents tend to under-
estimate their weight and over-estimate their height, thus lowering their initial BMI 
(Danubio, Miranda, Vinciguera, Vecchi, & Rufo, 2008; Elgar, Roberts, Moore, & Tudor-
Smith, 2005; Must & Strauss, 1999). Overall, among the very few studies that did 
examine the developmental transition from adolescence to young adulthood, 
inconsistencies in findings are evident among studies, and major methodological flaws 
exist within each study. 
2.2.4 Summary of literature review 
In summary, there are several conceptual, methodological, and analytical 
differences that exist in the present state of the literature. Despite many studies having 
examined this research question, the level and complexity of variation among existing 
research makes cross-study comparisons difficult, thus complicating interpretability of 
findings. These inconsistencies among studies combine with the various above-
mentioned limitations within studies. These include: lack of consistency in measuring 
body mass and depressive symptoms, failure to assess longitudinal change in outcomes, 
using only two waves of data, failure to examine reciprocal relationships, and a lack of 
transitional research between adolescence and young adulthood. Taken together, as the 
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literature currently stands, it is difficult to draw concrete conclusions about the 
prospective associations between body mass and depressive symptoms across 
adolescence and young adulthood. With these limitations in mind, the next section will 
highlight the rationale for this study, as well as its objectives and hypotheses. 
2.3 Plan of study, objectives, and hypotheses 
The purpose of the present study is to assess the association between two 
developmental processes, body mass and depressive symptoms, as adolescent’s transition 
into young adulthood. As can be deduced by the literature review presented above, 
several studies have already examined this research question. However, this study was 
conducted in order to address the major limitations and gaps of previous research in this 
area, as well as to contribute to some level of consistency that will help make cross-study 
comparisons possible in the future. Thus, strong conceptual, methodological, and 
analytical justifications were made throughout the following methods section. 
The specific objectives of this study are to: 1) examine individual trajectories of 
body mass and depressive symptoms as adolescents transition into young adulthood; 2) 
examine if changes in body mass over time are associated with changes in depressive 
symptoms over time; 3) examine whether initial levels of body mass predict changes in 
depressive symptoms over time, and/or vice versa; and 4) examine whether any of the 
above associations differ between sex. 
For objective (1), based on previous research (Ge et al., 2006; Kuczmarski et al., 
2002; Needham et al., 2010), we expect to find an increase in body mass over time and a 
decrease in depressive symptoms over time. Additionally, we expected to see body mass 
levels to be consistently higher for males than females (Shields, 2006), and depressive 
symptom levels to be consistently higher for females than males (Kuczmarski et al., 
2002; Locke & Newcomb, 2001), at all time points.  
Given that there is little research examining the association between changes in 
both health constructs over time, and the inconsistencies in the literature on the direction 
and strength of this association for males and females, objectives (2), (3), and (4) were 
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examined in a purely exploratory manner. However, we expect that, if a prospective 
association is evident between initial body mass and subsequent growth in depressive 
symptoms, it would be stronger for females than males. This hypothesis is made on the 
grounds of both the theoretical and empirical evidence presented in the literature review. 
As previously stated, weight concerns (Fredrickson & Roberts, 1997; Wadden & 
Stunkard, 1987), a greater level of weight-related stigmatization (Tang-Peronard, & 
Heitmann, 2008), and weight-teasing (Eisenberg et al., 2006; Tang-Peronard, & 
Heitmann, 2008) are more common in adolescent females than males. Furthermore, in 
both longitudinal studies that examined body mass affecting depressive symptoms during 
the transition between adolescence and young adulthood, associations for males were 
consistently nonsignificant across both studies (Goodman & Whitaker, 2002; Merten et 
al., 2008). 
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Chapter 3  
3 Methods 
3.1 Data 
3.1.1 Data source 
This study is based on a secondary data analysis of the National Longitudinal 
Survey of Children and Youth (NLSCY; Statistics Canada, 2009). The NLSCY is a 
population-based longitudinal study of Canadian children that follows their development 
and well-being from birth to early adulthood. The NLSCY was collected as a joint project 
of Human Resources Development Canada and Statistics Canada, and is designed to 
evaluate the determinants of developmental outcomes in Canadian children. The 
objectives of the survey include determining the prevalence of various risk and protective 
factors, understanding how factors and life events influence development, and collecting 
biological, social, and environmental information about children as they grow (Statistics 
Canada, 2009). 
3.1.2 Sampling design and data collection 
The target population for the original cohort in cycle 1 was selected from the 
Statistics Canada Labour Force Survey (LFS) and the National Population Health Survey 
(NPHS). The LFS is a monthly survey that collects labour market data from a national 
sample. It is representative of the civilian, non-institutionalized population aged 15 or 
over in Canada’s 10 provinces. The LFS excludes residents of Yukon, Nunavut, and the 
Northwest Territories, as well as people living on Indian reserves, full-time members of 
the Canadian Armed Forces, and inmates of institutions; thus excluding approximately 
2% of the population 15 years of age and older. Similarly, NPHS target population 
includes household residents in all provinces and territories, and excludes persons living 
on Indian reserves, on Canadian Forces Bases, and in some remote areas. Please see 
NLSCY microdata file (Statistics Canada, 2009) for more detail on the LFS and NPHS 
sampling design.  
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The NLSCY consists of eight biennial cycles in total (data collection for cycles 1 
to 8 occurred in 1994-95, 1996-97, 1998-99, 2000-01, 2002-03, 2004-05, 2006-07, and 
2008-09, respectively). Households that reported having at least one child between the 
ages of 0 and 11 years were selected as the household sample for cycle 1. For the first 
cycle, the children comprising the sample were selected at random, up to a maximum of 
four children per household. Approximately 25,000 children, ranging in age from 
newborn to 11 years inclusive, were initially selected in the ten provinces. The analyses 
for this study are based on data collected from the original cohort aged 10-11 years at the 
first cycle; thus, the following discussion will be limited to the procedures and 
characteristics that pertain to this cohort from the NLSCY longitudinal sample. 
Across collection cycles, several changes were implemented in the sampling 
strategy. At the second cycle, a maximum of two, instead of four, children were chosen 
for whom data were to be collected. Beginning in the third cycle, children who were not 
sampled included: deceased children, duplicate cases, children who were the wrong age 
for the survey, households that were not traceable in the second cycle, households that 
had moved permanently out of the country, children on Indian reserves, and households 
that were adamant refusals. Beginning in the fourth cycle, it was decided to exclude 
households after two consecutive cycles of non-response. Once respondents reach 18 
years of age, it is the decision of the respondent, not the person most knowledgeable 
(PMK), to respond to the survey. In other words, the response burden for the 18-year-old 
is not as great as it may be for younger children. Thus, in order to retain more cases, at 
the beginning of the fifth cycle, children who were 18-19 years of age were only 
excluded if there were three consecutive cycles of non-response. Beginning in cycle 7, 
the PMKs history of non-response was ignored for returning children who were 18 or 
older.  
At the first cycle, a household roster was completed for each household in the 
NLSCY asking about basic demographic information and dwelling conditions. Once this 
was completed, one child between the age of 0 and 11 was randomly selected from each 
household, and a question was asked about whom in the household was the person most 
knowledgeable (PMK) about the child. The PMK provided information about 
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him/herself, his/her spouse/partner, the selected child, and household members. Data 
from the PMK was collected in a face-to-face or telephone interview using computer-
assisted telephone interviewing (CATI). After the PMK gave permission, the interviewer 
provided a separate questionnaire to each child aged 10 to 11 years. These children were 
encouraged to self-complete the questionnaire in a private setting. Once completed, the 
questionnaire was sealed in an envelope and the parent was not permitted to see the 
completed questionnaire. In addition to the household component, questionnaires were 
mailed to, and returned by, teachers and principals of school-aged children for whom 
parental consent had been given.   
At subsequent cycles, similar procedures were followed as mentioned above. 
Namely, households that participated in the first cycle of the survey were contacted, both 
the PMK and spouse were asked questions, children older than 10 years were provided 
with self-complete questionnaires, and school-component questionnaires were mailed out 
to participating children’s teachers and principals, when applicable. 
3.1.3 Sample selection 
The purpose of this study was to examine the association between body mass and 
depressive symptoms as adolescents transition into young adulthood. Late adolescence 
was chosen as a starting point as opposed to early adolescence or childhood because 
depressive symptoms in these earlier developmental periods have a different pattern of 
symptoms (Carlson & Kashani, 1988; Ryan, Puig-Antich, Ambrosini, et al., 1987; 
Mitchell, McCauley, Burke, & Moss, 1988) and correlates (Jaffee, Moffitt, Caspi, et al., 
2002) compared to depressive symptoms in late adolescence and young adulthood. 
Younger adolescents with depressive symptoms are more likely to experience agitation 
and anxiety (Mitchell et al., 1988; Ryan et al., 1987), and older adolescents and young 
adults are more likely to experience psychomotor retardation (i.e., slower thought 
processes and physical activity; Ryan et al., 1987), which may be more closely related to 
weight gain. Thus, the population of interest is Canadian youth beginning in late 
adolescence and followed into young adulthood. Late adolescence is defined as 16-18 
years, and young adulthood refers to 18-30 years (Rindfuss, 1991). Thus, for the purposes 
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of the present study, an ideal nationally-representative population would prospectively 
follow adolescents from 16 years of age to 30 years of age. 
An initial longitudinal cohort of children (N = 2,488) participated in the NSLCY 
survey in 1994-95 when they were 10-11 years old, in 1996-97 when they were 12-13 
years old, in 1998-99 when they were 14-15 years old, in 2000-01 when they were 16-17 
years old, in 2002-03 when they were 18-19 years old, in 2004-05 when they were 20-21 
years old, in 2006-07 when they were 22-23 years old, and in 2008-09 when they were 
24-25 years old.  
In order to match the selected sample to the population of interest as closely as 
possible, youth were selected from the NLSCY once they were 16-17 years of age (i.e., 
starting at cycle 4, in 2000-01). The sample size for this group is 1,895 (47.9% female), 
representing 76% of the original cohort of 10-11 year olds at cycle 1. These youth were 
followed into young adulthood, until age 24-25. Although, it would have been ideal to 
have youth followed until age 30, the NLSCY currently only has data available until ages 
24-25. Although sampling procedures and data collection did not begin when these youth 
were 16-17 years of age, cross-sectional weights were used in all analyses (explained in 
detail below). Thus, the sample selected for the present study represents the Canadian 
population of adolescents aged 16-17 years as of January 1, 2001.  
Statistics Canada provides information on the overall participation rates of the 
initial 10-11 year olds for only five out of the eight cycles (96.1% in cycle 1, 91.2% in 
cycle 2, 87.5% in cycle 3, 75.1% in cycle 6, and 61.9% in cycle 8). However, 
participation rates for the entire longitudinal cohort (i.e., 0-11 year olds at cycle 1), as 
compared to the first cycle, are as follows: 86.5%, 91.5%, 89.2%, 84.5%, 81.3%, 82.4%, 
80.5%, and 68%, for cycles 1-8, respectively. 
3.2 Measurement instruments 
3.2.1 Body mass 
Body mass was assessed by BMI, which was calculated as weight in kilograms 
divided by height in meters squared. Height and weight were self-reported by individuals 
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at all five ages (i.e., when participants were 16-17, 18-19, 20-21, 22-23, and 24-25 years 
of age).  
BMI was kept as a continuous variable in all analyses for several reasons. First, as 
BMI does not measure fat directly, there is currently no consensus regarding cut-offs for 
defining obesity in adolescents (Sweeting, 2007). In contrast with adult populations, 
much less is known about the levels of risk associated with specific BMI levels in 
children and adolescents. Due to this uncertainty, statistical approaches have often been 
used in which the distribution for a population is determined and percentile values are 
arbitrarily chosen to distinguish those with the highest BMI from the rest of the 
population (e.g., 95th percentile). This approach has resulted in different reference groups 
that identify different BMI cutoffs for obesity and overweight status based on sex and 
age. For example, the CDC (Kuczmarski et al., 2002), the International Obesity Task 
Force (IOTF; Cole, Bellizzi, Flegal, & Dietz, 2000), and the WHO (WHO, 2006) have all 
identified different reference datasets for children and adolescents.  
Second, retaining the continuity in BMI levels allows researchers to examine 
individual heterogeneity over time, as well as associations between depressive symptoms 
and normal variations in relative weight, as distributed throughout the population (Hasler, 
Pine, Gamma, et al., 2004). Taking a more inclusive approach to body mass by 
examining weight as a continuous variable may be more appropriate for understanding 
the adverse health consequences and risk factors associated with higher BMI levels 
(Allison, Fontaine, Manson, Stevens, & VanItallie, 1999; Li, Rana, Manson, et al., 2006; 
Ogden, Carroll, Curtin, et al., 2006; Rashid, Fuentes, Touchon, & Wehner, 2003). Thus, 
given the lack of research identifying validated cutoffs for youth, as well as the benefits 
of examining weight as a continuous variable, the present study has kept BMI as a 
continuous predictor and outcome so that readers can interpret results with reference data 
as they see fit and results may be more meaningful within a population health context.  
3.2.2 Depressive symptoms 
Depressive symptoms were measured using the Centre for Epidemiological 
Studies- Depression Scale (CES-D; Radloff, 1977). This scale is used to measure the 
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frequency of symptoms in the public at large. Questions focus on affective components 
such as depressed mood, feelings of guilt and worthlessness, feelings of helplessness and 
hopelessness, psychomotor retardation, and sleep disorders (Radloff, 1977). Within the 
NLSCY, the original 20-item scale was reduced to 12 questions by Dr. M. Boyle of the 
Chedoke-McMaster Hospital, McMaster University. This short version CES-D scale was 
developed to assess levels of depressive symptoms during the past week, and has a 
Cronbach’s alpha of .85 (Poulin, Hand, & Boudreau, 2005). Participants were asked to 
rate on a four-point scale, from 0 (less than 1 day) to 3 (5-7 days), the occurrence of 12 
feelings, such as “I felt depressed” or “I felt hopeful about the future”, during the 
previous week. Three items on the scale were reversed scored so that higher scores 
indicated greater depressive symptoms. Severity ratings for each symptom were summed 
to form a continuous depressive symptom composite at each age, ranging from 0 to 36. 
The internal consistency of the scale was similar across the five ages (α = .84, .83, .80, 
.80, .82, for ages 16-17 to 24-25, respectively). 
Depressive symptoms were kept as a continuous variable in all analyses because 
depressive symptoms, like weight, occur on a continuum, and similar to those individuals 
who are overweight but not yet obese, individuals who do not meet clinically significant 
levels of depressive symptoms may still be at risk for mental health consequences 
(Napolitano & Foster, 2008). Thus, in order to capture these population-level variations 
in depressive symptomology, the present study focused on continuous depressive 
symptoms rather than clinically significant depressive symptoms. 
3.2.3 Age and sex 
Age and sex were both reported by the PMK at the very first cycle. Age at each 
subsequent cycle was derived by the child’s date of birth (as reported by the PMK during 
the first cycle of data collection) and the date of interview. For ease of interpretation, 
going forward, NLSCY cycles will be referred to by assumed median ages, with age 17 
representing cycle 4 (i.e., baseline), age 19 representing cycle 5, age 21 representing 
cycle 6, age 23 representing cycle 7, and age 25 representing cycle 8. 
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Response rates for variables of interest across all five ages are presented in Table 
2. For BMI, response rates ranged from 64.6-78.4% for males and 66.7-80.0% for 
females. For CES-D scores, response rates ranged from 64.6-70.2% for males and 67.5-
75.3% for females. 
 
Table 2: Sample size across ages. 
 
Variable Age 17 (%) Age 19 (%) Age 21 (%) Age 23 (%) Age 25 (%)
BMI 681 (68.9) 775 (78.4) 647 (65.5) 698 (70.6) 638 (64.6)
CES-D 653 (66.1) 671 (67.9) 643 (65.1) 694 (70.2) 638 (64.6)
Age 988 (100.0) 782 (79.1) 650 (65.8) 700 (70.8) 641 (64.9)
BMI 681 (75.1) 696 (76.7) 676 (74.5) 662 (80.0) 605 (66.7)
CES-D 678 (74.8) 665 (73.3) 683 (75.3) 677 (74.6) 612 (67.5)
Age 907 (100.0) 713 (78.6) 695 (76.6) 677 (74.6) 613 (67.6)
Males   
(n = 988)
Females 
(n = 907)
Note.  BMI: Body mass index. CES-D: Centre for Epidemiological Studies- Depression 
Scale. Percentages reflect response rates for original cohort of 17 year olds selected from 
cycle 4.
 
 
3.3 Analysis 
3.3.1 Modeling strategy 
As previously mentioned, the purpose of the present study is to assess the relation 
between two developmental processes, body mass and depressive symptoms, as 
adolescents transition into young adulthood. Latent growth modeling (LGM) was the 
analytical technique used to assess this research question. The following section will 
provide a justification of LGM as this analytical technique best represents the model of 
development and best complements the conceptual and methodological components of 
the present thesis.  
In LGM, a single underlying growth trajectory for a construct is estimated for 
each person across all ages (Curren & Bollen, 2001). In LGM, two latent factors are 
estimated: an intercept and a growth parameter. The intercept represents the starting point 
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(e.g., BMI at baseline). The intercept factor presents information about the mean, or 
average, starting levels for individual growth curves, as well as the variance in starting 
levels between individual growth curves (Duncan et al., 2006). The growth parameter 
represents the rate of change of an individual’s trajectory. This growth parameter may 
represent a linear slope or a more complex non-linear growth. Like the intercept factor, 
the growth factor consists of two components: the average, and the variance. That is, the 
growth factor presents information about the mean, or average, rate of change, as well as 
the variance in the rate of change across individuals. Taken together, the means for the 
intercept and growth represent the average trajectory for all individuals, and the variances 
for the intercept and growth represent the variability in trajectories across individuals. 
More information on techniques for estimating latent factors can be found in Duncan et 
al. (2006). 
Most previous research has examined the association between body mass and 
depressive symptoms using traditional panel models [e.g., autoregressive cross-lagged 
(ACL) approaches] to explore the temporal directionality of relations between depressive 
symptoms and body mass. Using ACL models, researchers have evaluated whether level 
of depressive symptoms at one point in time predicts body mass at a later point in time 
(and vice versa), while accounting for rank-order stability in variables over time (i.e., 
they examine the extent to which the rank-order standing of an individual within a group 
is stable or unstable over time; Duncan et al., 2006). Duncan and colleagues (2006) 
identified several criticisms of developmental models that incorporate these 
autoregressive effects.  
First, these types of statistical techniques do not provide information about 
developmental trajectories and individual-level change over time. In order to uncover the 
nature of development, it is necessary to assess individual-level change over time (Singer 
& Willett, 2003). Both body mass and depressive symptoms are developmental 
constructs. That is, they both change over time and across the lifecourse. For example, 
depressive symptoms increase throughout the adolescent years, peak during late 
adolescence, and decline into young adulthood (Ge et al., 2006). Similarly, body mass 
dramatically increases across childhood and adolescence and then levels off into 
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adulthood (Kuczmarski et al., 2002). Only by examining developmental trajectories using 
individual-level analysis could these changes over time be uncovered. Knowing that 
neither body mass nor depressive symptoms are linear processes during the transition 
between adolescence and young adulthood (Needham et al., 2010), it would be largely 
disadvantageous to use a design that is only appropriate when the growth process is 
irrelevant or known to be linear (Duncan et al., 2006). LGM identifies the process of 
change, and is used in analytical situations where describing the growth of a construct is 
of pivotal interest (Duncan et al., 2006), which is of central importance to the objectives 
of this thesis. As previously mentioned, the major objectives of the present thesis include 
examining individual trajectories of body mass and depressive symptoms as adolescents 
transition into young adulthood, examining if changes in body mass over time are 
associated with changes in depressive symptoms over time, and examining whether initial 
levels of body mass predict changes in depressive symptoms over time, and/or vice versa.  
A second criticism to ACL approaches is that they fail to provide adequate 
generalization for three or more time points. When more than two time points are 
included in a model, the best an autoregressive technique can do is examine change 
scores between any two points in time. This constraint is particularly important with 
respect to the present study, because, as highlighted above, both body mass and 
depressive symptoms are assumed to be nonlinear processes. In order to identify a 
nonlinear process, a minimum of three data points are required. Thus, an analytical 
process that is able to adequately capture changes across three or more data points, as 
LGM is able to do, is required.  
Lastly, as autoregressive models are only able to predict changes in the rank order 
of observations over time, they may fail to identify significant changes at the individual 
and group level if rank order stays the same between two time points. While the ACL 
approach may determine whether body mass at age 17 predicts depressive symptoms at 
age 19, it cannot provide any indication of whether body mass predicts individual-level 
change over many years in depressive symptoms, or whether the trajectories of these two 
health indicators are related. According to Duncan and colleagues, “an appropriate 
developmental model is one that not only describes a single individual’s developmental 
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trajectory, but also captures individual differences in these trajectories over time” (p. 3; 
2006). Using a person-centered approach, such as LGM, does provide this information. 
Using LGM, body mass level at one point in time can be used to predict change in 
depressive symptom scores across an extended period of time, and vice versa. 
Furthermore, it is possible in LGM to assess whether the trajectories of body mass and 
depressive symptoms are related to one another. Overall, utilizing a LGM approach will 
provide the best match for the developmentally-focused research objectives of the present 
study. 
Research using a LGM approach to examine the developmental associations 
between body mass and depressive symptoms is limited. In fact, only two studies have 
utilized this analytic approach for this research question (Needham et al., 2010; Stice & 
Bearman, 2001). While these studies represent important extensions in research on body 
mass and depressive symptoms by adopting LGM, they suffer from a number of 
limitations. Most notably, Needham and colleagues (2010) did not focus on a specific 
developmental period. Examining four cycles over 15 years is a particularly long time 
period of investigation, making associations vulnerable to confounding effects of 
developmental periods and life transitions. At the other extreme, Stice and Bearman 
(2001) examined only three cycles of data over two years, with 10-month intervals 
between data collection points. Measuring at short intervals may not allow enough time 
between cycles to effectively examine changes during a particular developmental period 
such as adolescence, which spans over six years. No study using LGM has looked 
specifically at the adolescent period and its transition into young adulthood. This is an 
important limitation, as the later years of adolescence and early young adulthood involve 
significant changes in both body mass and depressive symptoms (Ge et al., 2006; Kemper 
et al., 1999). 
In the present study, LGM was used to estimate individual trajectories of body 
mass and depressive symptoms, as well as examine the association between body mass 
and depressive symptoms, across five ages. This modeling strategy complements the key 
objectives identified in the plan of study. The first objective was to examine individual 
trajectories of body mass and depressive symptoms as adolescent’s transition into young 
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adulthood. By using data from five ages (i.e., from ages 17, 19, 21, 23, and 25), this first 
objective will be met by using LGM to model separate individual, or univariate, 
trajectories for body mass and depressive symptoms. In addition to linear changes over 
time, nonlinear changes for both body mass and depressive symptoms will be examined. 
This will allow us to investigate whether changes in either health outcome are stable over 
time, or if they plateau over time within the developmental period.  
The second objective was to examine if changes in body mass over time are 
associated with changes in depressive symptoms over time, and the third objective was to 
examine whether initial levels of body mass predict changes in depressive symptoms over 
time, or vice versa. LGM allows us to enter both univariate trajectories into a single dual-
trajectory model (i.e., a multivariate model), where intercept and growth parameters are 
estimated for both body mass and depressive symptoms. Specifying this multivariate 
model allows us to examine if the rate of change for body mass is associated with the rate 
of change for depressive symptoms, thus assessing if changes in body mass are associated 
with changes in depressive symptoms. This multivariate model also allows us to examine 
if the intercept for body mass predicts the growth for depressive symptoms, thus 
assessing if initial levels of body mass predict changes in depressive symptoms over time 
(and vice versa with the intercept of depressive symptoms predicting the growth of body 
mass).  
These analytical processes will be explained in greater detail in the results section.  
Overall however, it is clear that using an LGM analytical technique would be the best 
approach to study development, and more specifically, to investigate the key objectives 
of the present thesis.  
3.3.2 Data screening 
Since all BMI scores were derived from self-reported height and weight measures, 
there were some errors in both height and weight that needed to be examined prior to data 
analysis. Checks were used to flag improbable heights over time, as well as biologically 
implausible weight and BMI values. The following steps were taken to clean the height 
variable before computing BMI for each age. First, each individual’s height trajectories 
  
47 
were calculated from all eight cycles of data collection (n = 2,488). An assumption was 
made that height could not decrease over time. Thus, any individual whose height 
decreased at any adjacent point across the eight cycles of data collection was flagged. 
One thousand and sixty-eight of such individuals were flagged for one data point (416 for 
two data points, 90 for three data points, and 9 for four data points). Next, each height 
trajectory was individually examined in order to determine the point (or points) that most 
likely deviate from the rest of the trajectory. Once this point was flagged, an equation 
was used to replace it by applying an estimation using adjacent heights and age at time of 
interview.  
In addition, heights were imputed using the same equation if an individual 
provided data about weight, but not height. This was done as an attempt to maximize 
available weight data in order to compute BMI, and 27 such cases were identified. All 
analyses were rerun without these imputations, and similar results were found.  
Weight was checked by deleting any biologically implausible values based on an 
individual’s age and sex (Beck, Schaefer, Nace, et al., 2012). Three such deletions were 
made. BMI and depressive symptoms across all ages exhibited acceptable skewness and 
kurtosis [i.e., skewness < 3 and kurtosis < 10 – Kline, 2005] for structural equation 
modeling. 
3.3.3 Additional statistical considerations/adjustments 
3.3.3.1 Model fit 
Factor loadings are random, as each individual has a slightly different factor 
loading (explained below). Since maximum likelihood functions were used as a result of 
random factor loadings, traditional model fit indices, such as Comparative Fit Index 
(CFI), Tucker Lewis Index (TLI), and Root Mean Square Error of Approximation 
(RMSEA) could not be used. Instead, Akaike Information Criterion (AIC), Bayesian 
Information Criterion (BIC), and loglikelihood tests were used to compare models. More 
information on these fit indices may be found in (Burnham & Anderson, 2004). A 
loglikelihood chi square difference test was determined to be significant at the α = .01 
level. 
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3.3.3.2 Adjustment for variation in age at baseline 
Ideally, the application of LGM is dependent largely on data collection whereby 
individuals are observed at the same point in time (Muthén, 2002). However, 
participants’ ages ranged from 14.9 to 18.2 years at baseline. To calculate these age 
differences at time of interview for baseline estimates, participants’ age at baseline was 
subtracted by the median age (assumed to be 17, for ease of interpretability). Since 
participants’ ages at baseline in this study varied, these variations from the median age at 
baseline were controlled for, making the cohort homogenous with respect to starting age.  
3.3.3.3 Adjustment for departure from balance design 
An ideal application of LGM is also dependent on having equal spacing of 
assessments for all individuals (Muthén, 2002). However, for all cycles in the NLSCY, 
data collection spanned over two years. Thus, random factor loadings were used in each 
model in order to account for the variation between interview times among participants 
and across ages. For each age, factor loadings represented a participant’s exact age at 
time of interview (in years) subtracted by the assumed median age at baseline (i.e., 17). 
Thus, at age 19, factor loadings would have an approximate mid-point of 2 (ranging 
between 1 and 3), at age 21, factor loadings would have an approximate mid-point of 4 
(ranging between 3 and 5); at age 23, factor loadings would have an approximate mid-
point of 6 (ranging between 5 and 7); and at age 25, factor loadings would have an 
approximate mid-point of 8 (ranging between 7 and 9). The advantage of using this 
method is that we do not need to make an assumption that every participant was 
measured at the exact same time. Instead we can statistically allow measurement periods 
for each person across each cycle, to vary, as they did in reality. 
3.3.3.4 Missing data 
There are two major forms of missing data in the present analysis. First, not 
everyone who was originally sampled as a part of the original cohort at the first cycle of 
NLSCY data collection participated at the fourth cycle. Since analyses for the present 
study began at this cycle, when participants turned 16-17, only participants who 
responded at age 16-17 were included from the original cohort of participants. Thus, for 
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the present cohort, cross-sectional weights were computed by dividing each person’s 
baseline cross-sectional survey weighting by the cohorts’ average survey weighting. 
Cross-sectional weights were used in all analyses so that estimates at baseline represent 
the Canadian population of 16-17 year olds as of January 1, 2001. Given the complexity 
in the NLSCY sampling design with regard to stratification, multiple stages of selection, 
and unequal probabilities of selection of respondents, cross-sectional weights must be 
used in order to avoid bias in survey estimates and analyses (Statistics Canada, 2009).  
The second form of missing data was due to the longitudinal sequential design of 
the NLSCY.  For example, after baseline, some participants did not complete the survey 
at all time periods.  Missing data are assumed to be independent from values of the study 
measures; thus, it is reasonable to assume that these data are missing at random (Little & 
Rubin, 2002). Mplus offers superior handling of missing data (using Full Information 
Maximum Likelihood algorithm; FIML), for missing data points and for missing cases 
due to attrition. FIML uses all available data to generate maximum-likelihood estimates 
consisting of a vector of means and a covariance matrix among all variables in the data 
set (Wothke, 1996). FIML retains cases missing one or more cycles, and therefore avoids 
the use of biased parameter estimates that can occur with pair-wise or list-wise deletion 
(Arbuckle & Wothke, 1999; Schafer & Graham, 2002). 
3.3.3.5 Power/sample size calculations 
Very little is known about the exact estimates needed to generate strong power 
calculations for LGM because these types of analytic models are still considered 
relatively new techniques (Muthén, 2002). Furthermore, because of the complexity of the 
present model, as well as the large number of parameter estimates that are expected, more 
general guidelines identified by the literature for SEM will be used to argue a sufficiently 
large enough sample size. In general, the literature suggests that having about 200 
subjects per group provides sufficient statistical power needed for any LGM analysis 
(Hoyle, 1995; Ullman, 1996). Since a separate growth model will be estimated for each 
sex on both health outcomes, a total sample size of 400 (i.e., 200x2) is needed for 
sufficient statistical power for one model. The sample size from the original cohort at 
baseline is 1,895, which indicates a large enough sample of adolescents and young adults 
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to conduct an in-depth analysis of body mass and depressive symptom trajectories, 
separately for males and females. 
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Chapter 4  
4 Results 
4.1 Descriptive results 
This chapter begins with a discussion of the characteristics of the sample, 
including the average BMI and CES-D score at each age, as well as correlations between 
BMI and CES-D score at each age. These descriptive statistics will be presented 
separately for males and females. Following this, the findings from each research 
objective will be presented. As previously mentioned, the objectives of this study are to: 
1) examine individual trajectories of body mass and depressive symptoms as adolescents 
transition into young adulthood; 2) examine if changes in body mass over time are 
associated with changes in depressive symptoms over time; 3) examine whether initial 
levels of body mass predict changes in depressive symptoms over time, and/or vice versa; 
and 4) examine whether any of the above associations differ across sex. 
The total sample size for this study was 1,895 (47.9% female). Table 3 outlines 
the means and standard deviations for BMI and CES-D score across the five ages. As 
expected, for both males and females, average BMI increased from adolescence to young 
adulthood. For males, average BMI at age 17 was 23.0 and steadily increased by about 
0.6 points at each age until age 23, where average BMI plateaus at around 24.9. When 
males were 25 years old, the average BMI increased by about only 0.2 points. Standard 
deviations in BMI for males tended to stay relatively consistent over time (i.e., at around 
3.9 points). In females, compared to males, there was a more steady increase in average 
BMI over time. At age 17, the average BMI for females was 22.4. This average steadily 
increased to 22.8 at 19 years, 23.6 at 21 years, 23.9 at 23 years, and 24.5 at 25 years. 
Average BMI for females was consistently lower than males at every age. Furthermore, 
there were greater variances in average BMI for females than males at every age. 
Standard deviations in BMI for females tended to increase over ages, from 4.2 to 5.4.  
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Table 3: Means and standard deviations of study measures across five ages. 
 
Variable Age 16 Age 19 Age 21 Age 23 Age 25 
  
M (SD) M (SD) M (SD) M (SD) M (SD) 
        
 
BMI 
      
 Males 22.97 (3.92) 23.64 (3.96) 24.33 (3.92) 24.89 (3.91) 25.05 (4.05) 
 Females 22.43 (4.22) 22.77 (4.90) 23.57 (4.60) 23.86 (5.42) 24.55 (5.41) 
 
        
CES-D 
      
 Males 8.02 (5.72) 7.39 (5.58) 4.40 (4.59) 3.71 (4.04) 4.10 (4.37) 
 Females 10.29 (6.41) 8.49 (6.11) 5.91 (5.96) 5.13 (4.93) 4.91 (5.38) 
 
        
Age 16.9y (7m) 18.7y (7m) 20.8y (7m) 22.8y (7m) 24.8y (7m) 
 
       
Note. BMI: Body mass index. CES-D: Centre for Epidemiological Studies- Depression 
Scale. Higher scores for variables indicate higher BMI and CES-D scores. Scores 
reflect adjusted means. 
 
For both males and females, average CES-D score decreased from adolescence to 
young adulthood. For males, average in CES-D score (out of a possible 36 points) was 
8.0 at age 17. The average slightly decreased at age 19 to 7.4, and then drastically 
decreased at age 21 to 4.4. Following these ages, the average CES-D score plateaus at 3.7 
and 4.1 at ages 23 and 25, respectively. Standard deviations in CES-D score for males 
tended to decrease over ages, from 5.7 to 4.1. For females, the average in CES-D score 
was higher than the average in CES-D score for males at every age. In addition, the 
average in CES-D score demonstrated a more gradual decline across ages for females 
than they did for males. At age 17, the average in CES-D score for females was 10.3. 
This average decreased to 8.5 at age 19, 5.9 at age 21, 5.1 at age 23, and 4.9 at age 25. 
Although standard deviations in CES-D score for females also tended to decrease across 
ages, these standard deviations were greater for females than they were for males, at all 
ages. 
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Table 4 outlines the correlations between BMI and CES-D score at each age, 
separately for males and females. BMI was highly and significantly correlated across 
ages, for both males and females. Adjacent age correlations for BMI were highest, with 
Pearson correlation coefficients ranging from .76 to .84 for males, and from .74 to .84 for 
females (all p’s < .001). However, BMI at age 17 was still highly correlated with BMI at 
age 25 (.62 for males, and .67 for females; all p’s < .001). 
CES-D scores were also highly correlated and statistically significant across ages 
for both males and females, although to a lesser degree than BMI. As was the case with 
BMI, adjacent age correlations for CES-D scores was highest, with Pearson correlation 
coefficients ranging from .46 to .58 for males, and from .40 to .46 for females (all p’s < 
.001). CES-D scores were also highly correlated between age 17 and age 25, with 
Pearson correlation coefficients of .43 for males and .38 for females (all p’s < .001). 
Adjacent age correlations for CES-D scores were consistently higher for males than 
females, with the greatest difference between sexes occurring between ages 17 and 19, 
where CES-D scores were correlated at .58 for males and .40 for females. 
The correlation between BMI and CES-D score across ages was drastically 
different for males and females. For males, BMI and CES-D score correlations at the first 
two ages were not statistically significant (Pearson correlation coefficient of .02 at age 17 
and .04 at age 19; all p’s > .05). However, during the next three ages, correlations were 
negative and statistically significant. These correlations also increased in magnitude 
across ages: -.08 at age 21, -.11 at age 23, and -.14 at age 25 (all p’s < .01). The largest 
correlations for males were between BMI at age 21 and CES-D score at age 23 (-.21, p < 
.001), between BMI at age 21 and CES-D score at age 25 (-.21, p < .001), and between 
BMI at age 25 and CES-D score at age 23 (-.18, p < .001). 
For females, a completely different pattern of correlations emerged. BMI and 
CES-D score correlations within all ages were positive and statistically significant. The 
correlation magnitudes increased until age 21, with Pearson correlation coefficients of .08 
at age 17 (p < .05), .17 at age 19 (p < .001), and .22 at age 21 (p < .001). Following this 
peak, correlation magnitudes decrease slightly, with correlation coefficients of .08 at age 
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23 (p < .05), and .14 at age 25 (p < .01). The largest correlations for females were 
between BMI at age 17 and CES-D score at age 19 (.30, p < .001), between BMI at age 
19 and CES-D score at age 21 (.29, p < .001), and between BMI at age 17 and CES-D 
score at age 21 (.25, p < .001). 
The most striking sex differences between BMI score and CES-D score 
correlations were evident for the last three ages, where for males correlations were 
consistently negative and statistically significant, and for females, correlations were 
consistently positive and statistically significant. For example, the correlation between 
BMI score at age 21 and CES-D score at age 23 was -.21 for males and .13 for females 
(all p’s < .01). 
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Table 4: Correlations between BMI and CES-D score across five ages (males/females). 
BMI 17 years .76*** / .84*** .67*** / .79*** .68*** / .74*** .62*** / .67*** .02 / .08* .18*** / .30***      -.03 / .25*** .02 / .04      -.04 / .13**
BMI 19 years - .80*** / .76*** .73*** / .74*** .74*** / .61*** -.04 / .14** .04 / .17***      -.03 / .29*** -.10* / .14**      -.08* / .13**
BMI 21 years - - .84*** / .81*** .76*** / .70*** -.11* / .14**      -.08 / .23***    -.08** / .22***  -.21*** / .13**      -.21*** / .18***
BMI 23 years - - - .81*** / .74*** -.06 / .10* -.02 / .24***    -.10* / .24***    -.11** / .08*      -.15*** / .03
BMI 25 years - - - - -.14**/ .07 -.04 / .09*    -.12** / .14**    -.18*** / .14**    -.14** / .14**
CES-D 17 years
- - - - - .58*** / .40*** .45*** / .33*** .48*** / .36*** .43*** / .38***
CES-D 19 years - - - - - - .46*** / .42*** .44*** / .26*** .35*** / .22***
CES-D 21 years - - - - - - - .57*** / .46*** .42*** / .30***
CES-D 23 years - - - - - - - - .57*** / .41***
CES-D 25 years - - - - - - - - -
† p  < .06. * p  < .05. ** p  < .01. *** 
Variable CES-D 25 yearsBMI 19 years BMI 21 years BMI 23 years BMI 25 years CES-D 23 yearsCES-D 17 years CES-D 19 years CES-D 21 years
Note. BMI: Body mass index. CES-D: Centre for Epidemiological Studies- Depression Scale. Higher scores for variables indicate higher depressive symptoms and frequency of health risk behaviors. 
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4.2 Growth trajectories 
4.2.1 Objective 1: Univariate growth trajectories 
The first objective of this study was to examine individual trajectories of body 
mass and depressive symptoms as adolescents transition into young adulthood. This was 
done by using data from five ages (i.e., age 17, 19, 21, 23, and 25) to model separate 
univariate trajectories for BMI and CES-D scores.  
The intercept and growth factors are each defined by setting factor loadings to 
specify time points in the model. Since the intercept is constant over time, it is modeled 
by constraining the loadings for each time point to equal 1. For each of the univariate 
trajectories in the present thesis, the intercept factor loading was set to 1 at all time 
points. This was done in order to estimate the starting point for each trajectory as the 
baseline (i.e., age 17).  
The growth factor in a LGM represents change, and thus is modeled by a 
successive increase in factor loadings over time. For example, a linear increase in BMI 
over five time points may be modeled by constraining the loadings of the five time points 
to 0, 1, 2, 3, and 4, respectively. Growth factor loadings in the present thesis were set to 0 
at baseline (i.e., age 17), and set to random factor loadings, with an approximate mid-
point of 2 (at age 19), 4 (at age 21), 6 (at age 23), and 8 (at age 25). The exact growth 
factor loadings reflect the variation in interview times among participants across ages. 
They average at approximately 2, 4, 6, and 8 in order to reflect the approximate number 
of years each interview took place after the baseline interview at age 17. For example, a 
growth factor loading of 2 at age 19 represents an individual who was interviewed 
exactly two years after the first interview. As previously mentioned, the advantage of 
using random factor loadings is that they allow measurement periods for each person, 
across each age point, to vary, as they did in reality.  
Age at baseline (centered at 17) was entered as a covariate on the intercept for 
both the BMI trajectory and the CES-D score trajectory. Age was centered at 17 (median 
age) for baseline for ease of interpretability. As previously explained, age was entered as 
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a covariate for the intercept of both univariate growth models in order to control for the 
variations in age at baseline, thus making the cohort homogenous with respect to starting 
age. Homogenizing the cohort was necessary as LGM applications assume that all 
individuals are observed at the same point in time (Muthén & Muthén, 2004).  
Separate univariate trajectories were identified for BMI and CES-D scores by first 
testing each health outcome on a linear growth model followed by a quadratic growth 
model. Quadratic associations were examined to determine if BMI and CES-D scores 
followed a nonlinear growth trajectory from adolescence into young adulthood. 
Nonlinearity was examined because, as previously mentioned, body mass increases 
rapidly over childhood and adolescence and then plateaus during young adulthood 
(Kuczmarski et al., 2002). Furthermore, depressive symptoms peak during late 
adolescence and then decrease and plateau across young adulthood (Ge et al., 2006). 
Thus, in order to examine these nonlinear growths, quadratic associations were 
investigated. Chi square difference tests, using log likelihoods, were conducted to 
compare the linear model to the quadratic model for each health outcome. The linear 
growth model was chosen for all behaviours unless the χ2difference test between the 
linear model and the quadratic model indicated a significant difference for the model at p 
< .01. The model with the lowest AIC and BIC values was determined to be the better 
fitting model of the two. The model with the linear growth factor was the more 
parsimonious choice for BMI, χ2diff (6) = 8.96, p > .05. In contrast, the model with the 
quadratic growth indicated a better fit than the linear model for CES-D scores, χ2diff (6) = 
54.14, p < .001. 
Once univariate models were identified, sex differences were assessed (objective 
4). To do this, a chi square difference test was used to compare two sets of models: an 
unconstrained model and a constrained model. The unconstrained model is the original 
multi-group model in which parameters were estimated separately for each sex. This 
model produced different parameter estimates (i.e., mean and variance for both the 
intercept and growth) for males and females. The constrained model constrains the 
variance for both the intercept and growth to be equal between males and females, thus 
allowing the model to calculate the same estimates for both males and females without 
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differentiating on sex. This constrained model is equivalent to examining trajectories of 
BMI and CES-D scores for everyone in the sample. The chi square difference test 
indicates if estimates conducted by separating sex are statistically significantly different 
from estimates conducted without separating by sex. A significant chi square difference 
test here would indicate that estimates from each model are different enough from one 
another to statistically validate presenting results separately by sex (i.e., using the multi-
group model identifying sex differences). The chi-square difference test indicated that 
there were significant differences between the unconstrained model and the constrained 
model for CES-D scores, χ2diff (3) = 28.89, p < .001. However, the chi-square difference 
test indicated that there were not any significant differences between the unconstrained 
model and the constrained model for BMI, χ2diff (2) = 5.67, p = .059.  
Overall, chi square difference tests were used to determine the most parsimonious 
model for identifying the trajectory of BMI and CES-D scores, and to determine whether 
any sex differences exist in these trajectories. For BMI, the model with linear growth was 
most parsimonious, and there were no statistically significant sex differences for the 
trajectory of BMI. For CES-D scores, the model with a quadratic growth had a 
significantly better fit than the model with a linear growth alone, and there were 
significant sex differences for the trajectory of CES-D scores. Although, chi square 
difference tests indicated no sex differences, BMI trajectories will still be separated by 
sex for ease of interpretability and consistency across all research objectives. 
Results of univariate trajectories are shown in Table 5. In addition, fitted 
estimates for the univariate trajectories are presented in Figure 2. According to the 
univariate models, average BMI at onset (i.e., age 17) starts at 23.3 for males and 22.5 for 
females, and increases linearly across the study period, for both boys and girls, although 
boys have slightly elevated initial levels and growth over time than girls. There was a 
statistically significant amount of variance in the intercept and growth of BMI, for both 
males and females, indicating a large amount of inter-individual differences in starting 
points and growth of BMI for males and females. Although both variances were 
significant, there were larger variances in BMI for females than males, in both the 
intercept and growth. 
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According to the univariate trajectories, males have an average CES-D score of 
8.6 at onset (i.e., age 17), whereas females have an average CES-D score of 10.4 at age 
17. While average BMI increased over time, average CES-D scores started out high at 
age 17 and decreased over time. The quadratic trend indicates that, for this developmental 
period, this decrease slows down and plateaus at about age 23. CES-D scores started out 
higher, decreased at a slower rate, and plateau later for females compared to males. 
Variances in the intercept of average CES-D scores were statistically significant for both 
males and females, although these variances were larger for females compared to males. 
For both sexes, variances were statistically nonsignificant for CES-D linear and quadratic 
growth, indicating that there were few individual-level differences in the decline and 
plateau of CES-D scores.   
In summary, the first objective aimed to examine individual trajectories of body 
mass and depressive symptoms as adolescents transition into young adulthood, by 
modeling separate univariate trajectories for BMI and CES-D scores across five data 
points from age 17 to 25. Average BMI growth followed a positive linear trajectory for 
both males and females, with males having slightly (but not statistically significant) 
higher initial levels and growth in BMI, compared to females. Average CES-D scores 
decreased over time for both males and females. The trajectory for average CES-D scores 
over time was nonlinear, such that there was a gradual decrease from age 17 to age 21, 
and then CES-D scores tended to plateau into young adulthood. The trajectory for CES-D 
scores was significantly different for males and females, such that, on average, females 
had both a higher starting level of CES-D scores, as well as a slower decline in CES-D 
scores, compared to males. The variances for both trajectories, with respect to intercept, 
were statistically significant, meaning that there was a great deal of individual-level 
variation from average in the starting point of BMI and CES-D scores. Variances for the 
linear growth of BMI were also statistically significant for both males and females, 
indicating a great deal of individual-level variation in the linear rate of change of BMI. 
These variances were consistently larger for females than males. However, nonsignificant 
variances for both growth elements of CES-D trajectories indicate small variation in the 
rate of change of CES-D scores, for both males and females. 
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Table 5: Parameter estimates of the multi-group univariate growth models of BMI and CES-D scores, by sex.  
 
Intercept, Mean 
(Variance)
Linear growth, Mean 
(Variance)
Quadratic growth, 
Mean (Variance)
BMI Males 23.29*** (11.50***) 0.27*** (0.06**) -
Females 22.47*** (15.25***) 0.25*** (0.12***) -
CES-D Males 8.63*** (10.00***) -1.54*** (0.45) 0.12*** (0.01)
Females 10.42*** (11.91***) -1.36*** (1.35) 0.08** (0.03)
** p  < .01. *** p  < .001.
Note . BMI = body mass index. CES-D: Centre for Epidemiological Studies- Depression Scale. The 
total sample was N = 1793. All models had covariances between intercept and growth parameters 
(and linear and quadratic parameters, when applicable), as well as a path from age at baseline to 
intercept of health outcome. 
Variable
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Figure 1: Fitted estimates for univariate trajectories. 
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4.2.2 Objectives 2 and 3: Multivariate growth trajectory 
Objectives 2 and 3 will be presented together in the following section because 
they were both estimated within the same LGM. The second objective was to examine if 
changes in body mass over time were associated with changes in depressive symptoms 
over time.  
Achieving this involved several analytical steps. First, the two separate univariate 
trajectories identified from the first objective (i.e., the linear multi-group BMI trajectory, 
and the quadratic multi-group CES-D scores trajectory) were both entered into a single 
dual-trajectory model (i.e., a multivariate model). This multivariate model estimated an 
intercept and growth for BMI, as well an intercept and growth for CES-D scores. Second, 
within this multivariate model, a path between the BMI and CES-D scores for each age 
was added, as well as a path between the intercept of BMI and the intercept of CES-D 
scores. These paths were added in order to control for contemporaneous associations 
between BMI and CES-D scores at each age. This control would ensure that any 
prospective associations are not simply due to the correlation of both health outcomes at 
each age (Stice & Bearman, 2001).  
In addition, for both BMI and CES-D scores, a path was also added between the 
intercept to the growth parameter in order to control for baseline levels of each health 
outcome. Given the high stability of both health outcomes, this control would ensure that 
any changes seen in either BMI or CES-D scores over time were not due to their 
respective initial levels (Bradley et al., 2008).  
Finally, a path was specified between the growth of BMI and the growth of CES-
D scores. This path represents the covariance in the linear growth of both health 
outcomes, and allowed us to examine the second research objective of whether changes 
in BMI were associated with changes in CES-D scores, after controlling for 
contemporaneous associations at each age and initial levels of each health outcome.  
The third objective was to examine whether initial levels of body mass predict 
changes in depressive symptoms over time, and/or vice versa. In order to do this, two 
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paths were simultaneously added to the same multivariate model: one in which the 
growth of CES-D scores was regressed onto the intercept of BMI, and one in which the 
growth of BMI was regressed onto the intercept of CES-D scores. These paths allowed us 
to examine whether the intercept of BMI predicted the growth, or rate of change, in CES-
D scores, and whether the intercept of CES-D scores predicted the growth, or rate of 
change in BMI. More specifically, these two coefficients will estimate: 1) the degree to 
which initial levels of BMI at age 17 predict changes in the average decrease in CES-D 
scores over time; and 2) the degree to which initial level of CES-D scores at age 17 
predict changes in the average increase of BMI over time. 
Since age at baseline was significant in the BMI univariate trajectory, but not the 
CES-D scores univariate trajectory, a path from age at baseline was only specified to the 
intercept of BMI in the multivariate model. In addition, the variance for the quadratic 
growth term for CES-D scores was constrained to zero in the multivariate model since it 
was statistically nonsignificant in the univariate latent growth model. 
Results from the multivariate latent growth model are presented in Figure 3, 
separately for males and females. For males, with regards to objective 2, the linear 
growth of BMI was not associated with the linear growth of CES-D scores (p > .05). For 
objective 3, the path from BMI intercept to CES-D scores linear growth was not 
significant, β = -.018, p = .217, indicating that average starting levels of BMI did not 
predict changes in CES-D scores over time, for males. However, the path from CES-D 
scores intercept to BMI linear growth was negative and significant, β = -.016, p = .031, 
indicating that, on average, adolescent males who had higher initial depressive symptoms 
reported a slower increase in body mass over time, than adolescent males who did not 
have higher initial depressive symptoms.  
For females, with regards to objective 2, the linear growth of BMI was not 
associated with the linear growth of CES-D scores (p > .05). For objective 3, the path 
from BMI intercept to CES-D scores linear growth was negative and significant at a trend 
level, β = -.026, p = .052, indicating that, on average, adolescent girls who had higher 
initial body mass reported a slower decrease in depressive symptoms over time, than 
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adolescent girls who did not have higher initial body mass. However, the path from CES-
D scores intercept to BMI linear growth was not significant, β = -.009, p = .364, 
indicating that, on average, starting levels of depressive symptoms did not predict linear 
changes in body mass over time, for females.  
Variances in intercept and growth parameters for the multivariate model followed 
a similar pattern to variances for the univariate models. Namely, large and statistically 
significant variances were present in the intercept and linear growth of BMI, for both 
males and females, as well as the intercept of CES-D. In addition, all variances were 
larger in females than males.    
4.2.3 Objective 4: Sex differences 
As previously mentioned, the final objective was to examine whether associations 
between initial levels of body mass and changes in depressive symptoms, and vice versa, 
over time, vary across sex. In order to test whether the multivariate associations were 
invariant across sex, a multi-group analysis was performed in the same manner in which 
they were described for the univariate trajectories. Namely, invariance was tested by 
comparing the multivariate model in which all parameters were constrained to be equal 
between males and females to an unconstrained multivariate model in which all 
parameters were free to vary. The chi-square difference test indicated that there were 
significant differences between the unconstrained multivariate model and the constrained 
multivariate model, χ2diff (5) = 35.78, p < .001, indicating that some of the associations 
for the dual trajectory model differ across sex. More specifically, the association between 
average initial BMI and average changes in CES-D scores, as well as the association 
between average initial CES-D scores and average changes in BMI, were both different 
for males and females (objective 3). However, the association between the growth of 
BMI and the growth of CES-D scores were not different between males and females 
(objective 2). As mentioned above, chi-square difference tests for univariate models 
indicated that there were significant differences between the unconstrained model and the 
constrained model for CES-D scores, but not for BMI (objective 1).  
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Note:  BMI = body mass index. CES-D = Centre for Epidemiological Studies- Depression Scale. Multivariate latent growth model 
of BMI and CES-D across five ages. All values are unstandardized coefficients (as standardized coefficients cannot be estimated 
using random factor loadings). Not all residuals are shown. Quadratic variance was constrained to zero. Covariances between BMI 
and CES-D within each age also are not shown (e.g., BMI at age 17 and CES-D at age 17). Double-arrows refer to covariances 
among the factors. Although not shown, a path from age at baseline was added to the intercept of BMI.
† p < .06. * p < .05. ** p < .01.
 
Figure 2: Multivariate model testing bidirectional pathways between BMI and CES-D. 
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Chapter 5  
5 Discussion 
This chapter begins with a summary of the results. The summary includes a brief 
overview of the results, focusing on the main findings from the univariate and 
multivariate analyses pertaining to the study objectives. Following this summary, the 
results for each objective are discussed in context with previous research on adolescents 
and young adults. This discussion will provide a rationale and conceptual understanding 
of the associations examined in the present thesis, as well as the important public health 
implications of this study. The strengths and limitations of the current study, as well as 
the important conceptual, methodological, and analytical suggestions for future research 
are discussed next. Finally, this chapter concludes with an overall summary of the present 
thesis and the importance of research in this area. 
5.1 Summary of main findings 
 The main goal of this study was to identify the growth trajectories of body mass 
and depressive symptoms as adolescent’s transition into young adults, and to examine the 
associations between these growth trajectories. This main goal is composed of four 
specific objectives. These objectives were to: 1) examine individual trajectories of body 
mass and depressive symptoms as adolescent’s transition into young adults; 2) examine if 
changes in body mass over time were associated with changes in depressive symptoms 
over time; 3) examine whether initial levels of body mass predicted changes in depressive 
symptoms over time, and/or vice versa; and 4) examine whether any of the above 
associations differed by sex. 
 With respect to the first objective of examining individual trajectories of body 
mass and depressive symptoms, results indicated that the average BMI trajectory 
increased linearly from age 17 to 25, for both males and females. Average BMI levels 
started out higher and increased at a faster rate for males than females, although this 
difference was not statistically significant. There was a statistically significant level of 
variation in both the starting levels and linear growth of BMI, especially for females, 
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indicating that a great deal of individual-level variation exists in BMI trajectories. 
Furthermore, although there were increases over time in average BMI for both males and 
females, it is important to note that average BMI was within the normal weight range at 
all ages for both males and females, with the exception that average BMI for males at 25 
years of age was within the overweight range (Kuczmarski et al., 2002).  
The model-estimated trajectory for CES-D scores was negative and quadratic. 
That is, CES-D scores started out higher, and decreased until about age 21 where scores 
plateaud for the next two ages. The trajectory for CES-D scores was significantly 
different for males and females, such that females had both a higher starting level of 
CES-D scores, and a slower decline in CES-D scores, compared to males. Average CES-
D scores were within the minimal depressive symptoms range for both males and 
females, at all ages (Poulin et al., 2005). Statistically significant variance was only 
present in the intercept of CES-D scores for both males and females, and was greater for 
females, indicating a high degree of individual-level variation in starting levels of CES-D 
scores, particularly for females. On the other hand, variances in linear or quadratic 
growth for the CES-D trajectory were not statistically significant, indicating that the 
average decline and plateau for CES-D scores are relatively consistent across individuals. 
With respect to the second objective of examining if changes in BMI were 
associated with changes in CES-D scores, results showed that the linear growth of BMI 
was not associated with the linear growth of CES-D scores, for either males or females. 
That is, the rate of change in BMI was not associated with the rate of change in CES-D 
scores. 
For the third objective examining whether initial levels of body mass predicted 
changes in depressive symptoms over time, results showed that starting levels of BMI 
predicted change in CES-D scores over time for females, but not males. On average, 
adolescent girls who had higher initial BMI levels reported a slower decrease in CES-D 
scores over time, than adolescent girls who did not have higher initial BMI levels. This 
association was significant at a trend level. Furthermore, starting levels of CES-D scores 
predicted change in BMI over time for males, but not females. On average, adolescent 
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males who had higher initial CES-D scores reported a slower increase in BMI over time, 
than adolescent males who did not have higher initial CES-D scores.  
Finally, with respect to the fourth objective, examining whether any of the above 
associations differ across sex, results from chi square difference tests indicated that there 
were significant differences between males and females in the univariate model for CES-
D scores, and the multivariate model with BMI and CES-D scores.  However, there were 
no significant gender differences in the univariate model for BMI.  
5.2 Rationale for results 
5.2.1 Objective 1 
The results from the first objective were expected. As mentioned in the 
hypotheses above, we expected trajectories of body mass to increase over time, and 
trajectories of depressive symptoms to decrease and plateau from adolescence to young 
adulthood. We also expected that, at all ages, body mass would be higher for males than 
females, and depressive symptoms would be higher for females than males.  
According to the CDC growth charts, body mass increases from childhood to age 
20 are expected, and these increases follow a normal physical growth pattern 
(Kuczmarski et al., 2002). Body mass at these developmental periods is also expected to 
be higher for males than females, and reflects the fact that males generally have greater 
muscle mass than females (Tanner, 1989).  
Research on depressive symptoms in adolescents and young adults indicates that 
during early adolescence, depressive symptoms increase, until they peak in late 
adolescence, at around 17 or 18 years of age (Ge et al., 2006). This peak in depressive 
symptoms during late adolescence is expected, as adolescence is a period of heightened 
emotions (Dahl, 2004). Following this peak, depressive symptoms tend to decrease into 
young adulthood (Needham et al., 2010). Adolescents tend to develop better emotion-
regulation abilities as they age and develop into young adults (Kemper et al., 1999), thus 
accounting for the lower depressive symptoms we see over time. Although depressive 
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symptoms tend to generally decrease from adolescence into young adulthood, rates are 
still higher in females compared to males (Locke & Newcomb, 2001). 
5.2.2 Objective 2 
There is a paucity of previous multivariate LGM research on body mass and 
depressive symptoms, especially during adolescence and young adulthood. For these 
reasons, the second, third, and fourth objectives were examined in an exploratory way.  
With respect to the second objective, changes in body mass over time were not 
related to changes in depressive symptoms over time. As there were no studies in the 
previous literature that examined this particular research question, inferences cannot 
conclusively be made from the results presented here. However, because body mass and 
depressive symptoms tend to follow very different individual trajectories from late 
adolescence to young adulthood (i.e., body mass increases linearly and depressive 
symptoms decrease nonlinearly), it may not be surprising that changes in one health 
outcome over time are unrelated to changes in the other health outcome over time. 
Regardless, further research needs to be done in order to validate the findings with 
respect to this second objective. 
5.2.3 Objective 3 
5.2.3.1 Body mass affecting depressive symptoms 
Results from the third objective will be divided into two components: baseline 
body mass predicting change in depressive symptoms, and baseline depressive symptoms 
predicting change in body mass. For body mass affecting depressive symptoms in males, 
we found that, on average, BMI at age 17 did not predict growth in CES-D scores over 
time. This finding is similar to what was mentioned in the literature reviewed above; that, 
both studies which focused on the transition between adolescence and young adulthood, 
and investigated associations in both males and females, reported nonsignificant 
associations between body mass and subsequent depressive symptoms for males 
(Goodman & Whitaker, 2002; Merten et al., 2008).  
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Body mass during adolescence is largely driven by muscle mass in males (Tanner, 
1989). This increased muscle mass may be explained through greater physical activity, 
including greater participation in organized sports and strength training. Furthermore, 
popularity in adolescence is attributed to athletics for males (Chase & Dummer, 1992). 
Thus, it would be highly unlikely that, for the general population of adolescent males, 
higher body mass would be associated with an increase in subsequent depressive 
symptoms (Anderson, Cohen, Naumova, Jacques, & Must, 2007).  
For females however, the story is quite different. The present study found that, on 
average, adolescent girls with higher BMI at age 17 had a slower decline in CES-D 
scores compared to their peers. That is, although on average there was a reduction in 
depressive symptoms over time, females with higher body mass at age 17 were, on 
average, much slower at reducing their depressive symptoms than females without higher 
body mass at age 17; indicating that at each age, these females had higher depressive 
symptoms on average than their peers. 
These results are fairly consistent with the pattern of findings reported in the 
literature review section pertaining to studies examining body mass affecting depressive 
symptoms. More specifically, for female adolescents transitioning to young adulthood, 
body mass may lead to higher levels of depressive symptomology. Merten and colleagues 
(2008), for example, examined the association between body mass at age 12-18 and 
depressive symptoms five years later and found that, among females, obesity in 
adolescence was associated with higher depressive symptoms in young adulthood. 
Similarly, Boutelle and colleagues (2010) found that for adolescent girls, obesity 
predicted depressive symptoms one year later.  
Whereas popularity in adolescence is attributed to athletics for males, it is 
attributed to appearance for females (Chase & Dummer, 1992). Because females tend to 
place a great deal of subjective importance on their physical appearance (Wadden & 
Stunkard, 1987), female adolescents with higher body mass may be especially at risk for 
developing subsequent depressive symptoms through the internalization of biased 
attitudes (Boutelle et al., 2010). This internalization of biased attitudes may be the most 
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relevant causal pathway to explain the association between higher body mass and higher 
subsequent levels of depressive symptoms for females across adolescence and young 
adulthood.  
Although the internalization of biased attitudes is one potential causal pathway 
explaining the association between initial body mass and subsequent depressive 
symptoms for females, there are many other possible causal pathways, as explained in the 
literature review. Functional impairment in females with higher body mass may also lead 
them to develop higher depressive symptoms compared to their peers (Bornstein et al., 
2006; Lago et al., 2007). Physical activity tends to decline for adolescent girls, and this 
inactivity may prospectively lead to the development of higher depressive symptoms over 
time (Brown et al., 2005; Camacho et al., 1991; Farmer et al., 1988; Lampinen et al., 
2000; Paffenbarger et al., 1994; Strawbridge et al., 2002). 
While weight-teasing and neurobiological causal pathways to depressive 
symptoms may also play a role, they may not be as prominent in the present study 
because of the age-group studied, as well as the conceptualization of body mass and 
depressive symptoms. Weight-teasing tends to occur in childhood and young adolescence 
and rarely as much as older adolescents age into young adults (Hill, 2005).  
Furthermore, neurobiological causal pathways may play a role in the association 
between obesity classification and subsequent clinically significant depressive symptoms, 
but not in the association between high BMI and subsequent depressive symptoms. For 
example, obesity, but not necessarily high BMI, has been shown to predict subsequent 
depression through inflammatory pathways (Emery et al., 2007; Shoelson et al., 2007), 
HPA dysregulation (Pasquali et al., 2006; Walker, 2001), and increased risk of diabetes 
mellitus (Ajilore et al., 2007).  
5.2.3.2 Depressive symptoms affecting body mass 
With regards to the opposite direction of association (i.e.. depressive symptoms 
affecting body mass), results indicated that, on average, high initial CES-D scores did not 
lead to higher BMI growth in males or females. Although we found that depressive 
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symptoms did not predict higher body mass in either males or females, the reasons for 
this may be different. For girls, the association between depressive symptoms and 
subsequent body mass may only be significant when considering clinically significant 
depressive symptoms, which were not considered in the present study. For example, 
Anderson, Cohen, Naumova, and Must, 2006 reported that a MDD diagnosis in 
childhood and adolescence predicted a steeper increase in weight for females. 
In addition, dose-response studies have reported that the number of times an 
adolescent meets clinical criteria for a major depression diagnosis during adolescence 
predicts an increased risk of obesity in young adulthood (Richardson, Davis, Poulton, et 
al., 2003). These recurrent, or persistent, episodes of depression are much more common 
for females than males (Richardson et al., 2003), thus making it more likely for 
depression, when diagnosed at a clinical level, to lead to increases in body mass for 
females.  
In the literature review above, studies that investigated associations between 
depressive symptoms and subsequent body mass in both males and females reported 
nonsignificant associations for males (Goodman & Whitaker, 2002; Tanofsky-Kraff et 
al., 2006).  Furthermore, in line with our findings, there is some evidence that males are 
inclined to lose instead of gain weight when depressed (e.g., Carpenter, Hasin, Allison, & 
Faith, 2000). Carpenter and colleagues (2000) found that underweight status in men was 
associated with an increased risk of clinical depression and suicidal tendencies. In 
addition, using a community-based study of sixth grade students, Rhew and colleagues 
(2008) found that adolescent boys with clinically significant depressive symptoms at 
baseline reported lower subsequent BMI one year later, compared to their non-depressed 
peers. Finally, there has also been some cross-sectional research supporting an inverse 
relationship between depressive symptoms and body mass among adult men (Crisp & 
McGuiness, 1975; Crisp, Queenan, Sittampaln, & Harris, 1980; Kittel, Rustin, Dramaix, 
et al., 1978). Similarly, the correlational analyses of the present study showed significant 
and negative relations between body mass and depressive symptoms for adolescent and 
young adult males.   
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As previously mentioned, body mass during adolescence is largely driven by 
muscle mass for boys (Tanner, 1989), partially explained by greater physical activity and 
participation in organized sports. Popularity for adolescent boys is largely attributed to 
athletics and organized sport participation (Chase & Dummer, 1992) because males tend 
to prefer a large and muscular body as opposed to a thin one (Herva et al., 2006). Boys 
with depressive symptoms may be less likely to increase their body mass through 
participation in physical and muscle-building activities because these activities occur in 
highly social contexts during adolescence. Depressive symptoms also may be associated 
with a lack of athletic ability in boys, which may be indexed by a low body mass. 
Furthermore, a moderational process may occur, such that depressed males start out with 
lower body mass (Carpenter et al., 2000), and also tend to gain less weight over time 
(Barefoot et al., 1998). 
Finally, for both males and females, the heterogeneity of depressive symptoms 
may make it difficult to prospectively affect increases in body mass. More specifically, 
depressive symptoms include either increased or decreased appetite, and there may be a 
sub-sample of depressed adolescents who report losing weight, or a failure to gain weight 
over time as opposed to gaining weight (Kendler, Eaves, Walters, et al., 1996). This 
inherent heterogeneity in the manifestation of depressive symptoms may confound 
associations between depressive symptoms and subsequent body mass, for both males 
and females. 
5.3 Implications 
The results of the present study have many academic and public health 
implications. One major such implication is the importance of considering sex in the 
associations between body mass and depressive symptoms in adolescents and young 
adults. These associations differ greatly for males and females, and these differences need 
to be taken into consideration in future research, as well as within a public health 
perspective. Females tend to place a greater importance on appearance and thinness than 
males, and they are also more like to experience negative feelings, such as depressive 
symptoms, associated with their weight status (Wadden & Stunkard, 1987). Thus for 
females, higher body mass could be indicative of future mental health problem. For males 
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however, it is particularly important to pay attention to lower weight status and 
depressive symptoms. Depressed males may be failing to attain the proper nutrients and 
exercise they need in order to build muscle mass. Thus, depressive symptoms in boys 
may lead to a failure to fully physically develop.  
A population-based strategy targeting these two health outcomes would be most 
effective if it focused on preventing depressive symptoms in adolescent boys, and 
preventing overweight conditions in adolescent girls. For males, attenuating the risk 
factors for depressive symptoms early in the lifespan is critically important. In addition, 
males with higher depressive symptoms should be closely monitored with regards to diet 
and physical exercise in order to ensure proper development into young adulthood.  
Since higher BMI levels in adolescent girls had an effect on their rate of change in 
CES-D scores as young adults, it is important for adolescent girls to take the necessary 
steps to achieving healthy body mass during the teenage years. Weight-related changes 
can be promoted by parental and societal influences. Parents of teenagers can help in 
many ways. First, since they are the primary models in developing the food preferences 
and habits for their household, they can begin by evaluating their own lifestyles in terms 
of health-related quality (Benton, 2004; Merten et al., 2008). Also, by practicing 
authoritative parenting (Baumrind, 1966), parents can promote positive self-regulation 
(Patock-Peckham, Cheong, Balhorn, & Nagoshi, 2001). This positive self-regulation in 
their teens allows them make healthier food and activity choices of their own, while still 
having guidance and monitoring from their parents (Merten et al., 2008). 
On a societal level, interventions need to be developed addressing the 
discrimination of individuals with higher body mass in educational, professional, and 
social settings (Merten et al., 2008). These interventions are particularly important for 
women, as research has shown that recruiters and employers judge these individuals 
capabilities based on weight-related biases (Ding & Bornhop, 2005; Tunceli & Williams, 
2006). Finally, school administrators and directors need to be aware of the detrimental 
effect that poor nutrition and exercise habits on an adolescent’s psychological well-being 
over time (Merten et al., 2008). 
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Care providers should be aware of the extent to which body mass and depressive 
symptoms interact in some individuals. More specifically, they should be alert to the 
possibility of depressive symptoms in their patients with obesity, and should screen for 
these symptoms appropriately, as well as monitor their changes over time (Faith et al., 
2011). Health care providers should also be aware of and monitor weight changes in 
patients that present with clinically significant depressive symptoms. 
5.4 Strengths 
The major strength of the present study was that it addressed the majority of 
within-study limitations of past research. These include: lack of consistency in measuring 
body mass and depressive symptoms over time, failure to assess longitudinal change in 
outcomes, using only two waves of data, failure to examine reciprocal relationships, and 
a lack of transitional research between adolescence and young adulthood. The present 
study used the same measures to assess body mass and depressive symptoms across all 
five ages. That is, at all ages, self-reported height and weight were used to calculate BMI, 
and self-reported CES-D scores were used to measure depressive symptoms. We assessed 
longitudinal change in both health outcomes by controlling for baseline levels of each 
outcome during analytical modeling. In order to effectively assess growth over time in 
both outcomes, we used five data-points over an eight-year period. The present study 
examined, simultaneously, the reciprocal prospective associations between body mass 
and depressive symptoms. Finally, in order to gain an understanding of how these 
developmental processes are associated as adolescents age, we assessed the prospective 
associations between these two health outcomes during the transition from adolescence to 
young adulthood. 
In addition, strong conceptual, methodological, and analytical justifications were 
made throughout the methods section in order to contribute to a level of consistency that 
will ease cross-study comparisons in the future. First, late adolescence was chosen as a 
starting point because depressive symptoms in earlier developmental periods has a 
different pattern of symptoms (Carlson & Kashani, 1988; Ryan et al., 1987; Mitchell et 
al., 1988) and correlates (Jaffee et al., 2002) compared to depressive symptoms in late 
adolescence and young adulthood. Although, in order to fully capture young adulthood, 
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an ideal follow-up period would have been until age 30 (Rindfuss, 1991), the constraints 
of the data source used only allowed examination up to age 25. The NLSCY was chosen 
because it is the largest population-based longitudinal study of Canadian children that 
follows their development and well-being from birth to early adulthood (Statistics 
Canada, 2009).  
Second, BMI was kept as a continuous variable in order to take a more inclusive 
population-based approach to body mass. Similarly, CES-D scores were measured as a 
continuous variable in order to capture heightened depressive symptoms in individuals 
who do not meet criteria for clinically significant depressive symptoms.  
Third, in order to more accurately capture the developmental objectives of the 
study, the analytical procedure of LGM was used as opposed to an autoregressive 
modeling approach. No study to date has used LGM to examine, specifically, the 
adolescent period and its transition into young adulthood. This is an important limitation, 
as the later years of adolescence and early young adulthood involve significant changes 
in both body mass and depressive symptoms (Ge et al., 2006; Kemper et al., 1999).  
Finally, many steps were taken during the data screening and analysis phase to 
ensure validity in results. These steps included: using checks to flag and correct 
improbable height and BMI over time; adjusting for variation in age at baseline; adjusting 
for the variation in interview times among participants and across ages; applying sample 
weights so that estimates represent the Canadian population of 16-17 year olds as of 
January 1, 2001; and using FIML to handle missing data by using all available data to 
generate maximum-likelihood estimates. 
5.5 Limitations 
Although the present thesis had major strengths over previous studies, there were 
also a few limitations. These limitations include: using BMI as a proxy for adiposity; use 
of self-reported height and weight to calculate BMI; the low response rate for both BMI 
and CES-D; and follow-up period and length of intervals. These limitations will be 
discussed in greater detail below. 
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The first limitation concerns using BMI as a proxy for adiposity. This limitation is 
particularly relevant for the adolescent period, as gains in both muscle and bone mass can 
be substantial (Tanofsky-Kraff et al., 2006). Thus, changes in BMI may reflect these 
increases in muscle and bone mass, and not necessarily changes in fat mass. Although, 
density-based methods (e.g., underwater weighting) and scanning methods (e.g., DEXA) 
are the gold standard for assessing overall body fat and fat distribution, factors other than 
accuracy in body fat estimation need to be considered when deciding on an ideal measure 
of body fat (Power, Lake, & Cole, 1997). Factors such as accessibility, simplicity, cost 
and ease of use, and acceptability are all important considerations. Thus, using gold 
standard measures such as DEXA would not be feasible in a large-scale population study 
since the test must be performed in a major medical facility, and the equipment is very 
expensive and must be operated by a skilled technician (Lobstein et al., 2004). In 
addition, the procedure itself takes about 20 minutes and requires a very cooperative 
subject (Lobstein et al., 2004). Overall, feasibility restrictions exist for all of the density-
based and scanning methods, making them unsuitable as measures of body fatness for the 
present study.  
BMI has been recommended as the measure of choice for epidemiologic and 
population-based research because it is relatively easy to implement (Dietz & Robinson, 
1998). BMI also correlates well with direct measures of total body fat, including DEXA, 
as well as with health measures such as blood pressure, adverse lipoprotein profiles, 
atherosclerotic lesions, serum insulin levels, and diabetes mellitus in adolescent samples 
(Dietz & Robinson, 1998). Overall, research has documented that BMI is a valid measure 
of adiposity, especially for population-based research (Garrow & Webster, 1985).  
A second major limitation concerns the use of self-reported height and weight to 
calculate BMI. Individuals tend to under-estimate their weight and over-estimate their 
height (Elgar et al., 2005; Danubio et al., 2008; Morrissey, Whetstone, Cummings, & 
Owen, 2006), potentially leading to an inaccurate estimate of BMI. This inaccurate 
estimate would be especially problematic if self-reported height and weight are 
differentially biased between depressed and non-depressed individuals (Rhew et al, 
2008). In this specific situation, prospective associations between BMI and depressive 
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symptoms may be biased. For example, individuals who suffer from depression may be 
more prone to negative self-perceptions and greater self-criticality (Lewinsohn, Gotlib, & 
Seeley, 1997). This lower self-appraisal, in turn, may translate to more realistic height 
and weight self-reports than the height and weight reported by non-depressed individuals 
(Alloy & Abramson, 1988). Although a valid concern, there are several considerations 
that need to be made with respect to this particular limitation.  
First, these inaccuracies in self-reported height and weight reflect the specific 
developmental period under examination (Rhew et al, 2008). Biased estimates from self-
reported weights tend to be the greatest under age 14 (Himes & Faricy, 2001). Rhew and 
colleagues (2008) also concluded that the specific developmental period of early 
adolescence might be a time where self-reports are particularly inaccurate. Strauss (1999) 
found that in young adolescents aged 12-16, inaccuracies were more likely to occur for 
the younger aged youth compared to the older youth. Another study showed that BMI 
under-reporting is minimal in young adults between ages 20 and 40 (Schutz & Woringer, 
2002). Anderson and colleagues (2006) further commented that self-reported height and 
weight tend to be more accurate in adults and older adolescents. Several studies have, in 
fact shown a high correlation between BMI calculated from self-reported height and 
weight and BMI calculated from measured height and weight for older adolescents and 
young adults (Attie & Brooks-Gunn, 1989; Galambos, Almedia, & Peterson, 1990; 
Himes, Hannan, Wall, & Neumark-Sztainer, 2005). 
 Second, the discrepancies between self-reports and physical measurements tend to 
mainly occur at the extremes of the BMI distributions (Kuskowska-Wolk, Bergstrom, & 
Bostrom, 1992; Sorensen, Stunkard, Teasdale, & Higgins, 1983). Thus, a report bias of 
individuals under-reporting BMI at higher BMI levels would affect results by making 
estimates conservative (Ternouth, Collier, & Maughan, 2009). 
 Finally, several validation studies have stated that the bias of self-report BMI is 
too small to affect conclusions about associations in large-scale epidemiological studies 
(Stunkard & Albaum, 1981; Stevens, Keil, Waid, & Gazes, 1990). Validation studies also 
suggest that the self-report bias is unlikely to affect conclusions about associations 
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between body mass and psychological outcomes, such as depressive symptoms, 
particularly in longitudinal studies (Stunkard & Albaum, 1981; Stevens et al., 1990). 
Authors suggest that the self-reported BMI biases associated with depressive symptoms 
are most likely to operate in cross-sectional analyses instead (Hasler, Pine, Kleinbaum, et 
al., 2005).  
These biases are likely not to impact longitudinal studies because the self-report 
measure is from the same individual over time, thus reducing the amount of bias to only 
one source of bias over all ages. That is, by consistently relying on self-reported height 
and weight throughout all ages, we have only a single source of bias. Thus, increases in 
BMI over time cannot be due to the tendency for individuals to under-estimate their 
weight and over-estimate their height, because the same individuals are providing 
estimates for their height and weight over time. As previously mentioned, Franko and 
colleagues (2005), had inconsistent reporting sources for height and weight, where self-
reports were used at the first wave and measured height and weight at the second wave. 
Thus, the increase in BMI may reflect a true consistency in BMI that was not captured in 
the first wave because self-reports of height and weight would have had the effect of 
lowering their initial BMI (Elgar et al., 2005; Danubio et al., 2008).  
The third major limitation was the low participant response rate throughout all 
ages. As Table 2 indicates, after age 17, participation rates dropped in subsequent cycles. 
From ages 19 to 25, participation rates were 79%, 71%, 73%, and 66%, respectively. The 
biggest decrease in participation occurred between age 17 and 19, where there was a 20% 
drop in participation. A decrease in retention is expected to occur within longitudinal 
studies (Hansen, Tobler, & Graham, 1990). In a meta-analysis on attrition rates, Hansen 
and colleagues (1990) suggested that studies with retention rates above 71.8% at 24 
months, and above 67.5% at 36 months, would be judged to have acceptable and 
interpretable rates of retention. As retention rates were 79% at the age 19 (i.e., two years 
after baseline), this level of attrition occurring between age 17 and 19 of the current study 
is acceptable. Furthermore, at all ages within the current study, retention rates were 
higher than the acceptable rate that was defined by Hansen et al., (1990) for three years 
after baseline. These findings indicate that, although retention rates decreased over the 
  
80 
course of the present study, at eight years after baseline, retention rates were still within 
the acceptable range defined at three years after baseline. Although these retention rates 
were acceptable, there is a possibility that data is not missing at random if individuals 
with higher body mass and/or depressive symptoms were more likely to drop out of the 
study.  
The final major limitation of the present study is that the starting age point 
examined, as well as the length in time of follow-up, may have affected our findings. 
That is, we began our analyses at age 16-17, and measured change up until age 24-25. 
Depressive symptoms at age 16 may not affect changes in body mass up until age 25. For 
example, Richardson et al., 2003 examined this research question using two cohorts; one 
cohort was 11-15 years old at baseline and 26 at follow-up, and the other was 18-21 years 
old at baseline and 36 at follow-up. The authors found that depression at ages 11-15 was 
not a significant predictor of obesity at age 26 for either males or females. However, 
females with depression at ages 18-21 had an increased risk of obesity at age 26. This 
study suggests that the effect of depressive symptoms on subsequent body mass may be 
more likely to occur when the time points are closer together rather than farther apart. 
Thus, examining the associations over an 8-year period, beginning at 16-17 years, may 
have been too long or too early to see an association between depressive symptoms and 
subsequent body mass. 
These limitations, although not major, should be examined in greater detail in 
future studies researching the association between body mass and depressive symptoms. 
Namely, associations should be examined using gold standards for BMI assessment, 
including measured height and weight. In addition, analyses should be replicated on 
various ages and interval lengths between adolescence and young adulthood in order to 
best understand what is occurring during this developmental transition. 
5.6 Future research 
The public health implications presented above can only be drawn from tentative 
conclusions from the exploratory results reported in the present study.  Several authors 
have concluded that better-designed studies are needed to draw more reliable conclusions 
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on the prospective association between body mass and depressive symptoms (Fabricatore 
& Wadden, 2004; Liem et al., 2008). For example, Friedman and Brownell, 1995, 
suggested that authors include large, nationally representative samples, consistent 
definitions and measurements of body mass, valid assessment tools, and appropriate 
control groups. Faith et al., 2001 also encouraged authors to use standardized and 
validated assessments of depressive symptoms, as well as control for baseline levels of 
the follow-up dependent variable. 
As previously mentioned, the variations that occur at the conceptual, 
methodological, and analytical levels, may explain a great deal of the disparity in results 
of studies investigating the prospective association between obesity and depression. 
Conceptually, consistencies do not exist with regards to the developmental periods 
studied, the operationalization of body mass and body mass comparison groups, the 
operationalization of depressive symptoms, and the populations studied. 
Methodologically, there are large variations among the length of intervals, source of 
height and weight measurements, reference tools for establishing body mass cutoffs, and 
tools for measuring depressive symptoms. Analytically, studies varied in the number of 
measurement points used for analyses, the statistical techniques they used, and the 
covariates controlled for to assess prospective associations between body mass and 
depressive symptoms. 
 Thus, as it currently stands, public health implications can only be drawn from 
tentative conclusions. A major goal for future studies should be to strive toward greater 
consistency in this area of research. A higher level of precision in conceptualizations, 
methodologies, and analyses used across studies would effectively translate into less 
variety in reported results. Having less variety in results across studies would allow 
researchers to confidently state research conclusions and public health implications based 
on evidence. In order to build research towards this higher level of consistency between 
studies, authors should strive to provide strong justifications for the operationalization of 
concepts, as well as the methodologies and analytical techniques used. 
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In addition to greater consistency between studies, future research needs to 
examine more clearly the causal mechanisms involved in the prospective association 
between body mass and depressive symptoms (Luppino, de Wit, Bouvy, et al., 2010). 
Mediators should be selected based on the direction of the association examined and the 
theoretical rationale. As mentioned in the literature review above, potential causal 
pathways for body mass affecting depressive symptoms include the internalization of 
biased attitudes towards obesity, weight-teasing, neurobiological causal pathways, and 
functional impairment. The potential causal pathways through which depressive 
symptoms affects body mass include neurobiological causal pathways and affect 
regulation, and impaired sleep quality and physical inactivity. Once research has clearly 
established whether prospective associations between body mass and depressive 
symptoms exist, these causal pathways need to be explored in order to understand the 
mechanisms linking their association. 
Several studies have also reported null results when examining the prospective 
association between body mass and depressive symptoms (Clark et al., 2007; Goodman 
& Whitaker, 2002; Jansen et al., 2008; Rhew et al., 2008; Tanofsky-Kraff et al., 2006). 
These studies are also important, and reasons for null results for a particular 
developmental group should be more closely examined. For example, one line of 
reasoning may be that perception of and dissatisfaction with weight may be of greater 
importance for predicting depressive symptoms than weight per se (Stice, Hayward, 
Cameron, Killen, & Taylor, 2000). For example, Jansen and colleagues (2008) reported 
that body weight perception, and not weight status (self-reported or measured), was 
associated with mental health indicators among 12-13 year-olds.  
This association may be especially relevant for adolescent and young adult 
females than males, given the higher level of concern for being thin. According to Kittel 
and colleagues, adolescent girls aged 11-19 reported significantly less satisfaction with 
their bodies than adolescent boys (1978). In addition, Douty and colleagues found that 
59% of normal-weight female college students reported low satisfaction with their bodies 
(Douty, Moore, & Hartford, 1974). In another study, approximately 50% of girls in grade 
10-12 believed that they were overweight, and nearly two-thirds wanted to lose weight 
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(Stunkard, 1957). Most of the boys however were either satisfied with their weight or 
believed they were too thin. Interestingly, the prevalence of overweight status was 
identical in both groups. These findings highlight the importance of perception in the 
association between body mass and depressive symptoms, particularly for females.   
Stice and Bearman (2001) investigated associations within a sample of female 
adolescents from northern California, using three cycles of data over 10-month intervals. 
The authors hypothesized that neither starting levels of BMI nor changes of BMI over 
time would affect changes in depressive symptoms over time. Instead it was hypothesized 
that other variables would explain the growth in depressive symptoms across 
adolescence, including perceived pressure to be thin, thin-ideal internalization, body 
dissatisfaction, dieting, and bulimic symptoms. Growth curve analysis was used to 
examine whether initial levels of BMI predicted change in depressive symptoms over 
time, and whether change in BMI predicted change in depressive symptoms over time. 
Neither of these associations were significant. However, all other variables hypothesized 
to explain changes in depressive symptoms were significant. The authors concluded that 
body image and eating disturbances, but not BMI, contribute to the growth in depressive 
symptoms among female adolescents. Overall, these mechanisms need to be explored 
more clearly in future research. 
Finally, it would also be useful for future studies to examine associations across 
different developmental periods (Faith et al., 2011). We cannot currently infer causality 
because increases in body mass and depressive symptoms may have begun before age 17. 
Therefore, there may be a different temporal picture before these ages as well as after age 
25.  Future research is needed to apply the same methodologies to early adolescence as 
well as adulthood in order to better understand the predictive relationship between body 
mass and depressive symptoms. The association is most likely a bidirectional association, 
but different directional associations may apply depending on age group and sex. 
Although depressive symptoms in adolescence did not predict higher body mass in young 
adulthood in the present study, an individual’s mental state may begin to influence weight 
status as they become older. For example, when examining women 22-27 years old at 
baseline, Ball and colleagues (2009) found that decreases in weight predicted increases in 
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depressive symptoms three years later. For this age group, body image issues may not be 
as prominent in females, and instead, decreases in weight could reflect the occurrence of 
stressful life events, resulting in weight loss and depressive symptoms. Overall, exploring 
the associations across the lifecourse is important in order to fully understand 
developmental influences on both body mass and depressive symptoms. 
5.7 Conclusion 
In conclusion, the goal of this thesis was to examine longitudinally the 
associations between body mass and depressive symptoms during the transition from 
adolescence to young adulthood, and to investigate if and how these associations differ 
for males and females. It was conducted in order to address the major limitations and 
gaps of previous research in this area, as well as to contribute to some level of 
consistency that will help make cross-study comparisons possible in the future. Results 
showed that, on average, adolescent girls with higher initial BMI levels reported a slower 
decrease in CES-D scores over time, than adolescent girls who did not have higher initial 
BMI levels. In addition, on average, adolescent males with higher initial CES-D scores 
reported a slower increase in BMI over time, than adolescent males who did not have 
higher initial CES-D scores.  
Understanding the development and course of body mass and depressive 
symptoms requires a lifecourse perspective for many reasons.  First, both of these health 
outcomes have determinants early in life, and can often persist from adolescence into 
adulthood (Bradley et al., 2008; Guo et al., 2002). They can develop into chronic 
conditions that most likely require lifelong monitoring and management (Schwartz, 
1998). Thus, studying how body mass and depressive symptoms independently change, 
as well as how they are associated over time, will aid in understanding the course and 
consequences of both health constructs. Furthermore, understanding the predictive factors 
associated with changes in body mass, as well as the predictive factors associated with 
depressive symptoms, is important for preventing negative health outcomes across the 
lifecourse. Finally, preventing increases in either body mass or depressive symptoms will 
be most effective when it is informed by an understanding of the etiological pathways 
involved in their development (Anderson et al., 2006). 
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Appendix 
Appendix A: Supplementary Literature review tables. 
Anderson, 
Murray, 
Johnson, 
et al., 
2011
Random sample from 
multi-center group-
randomized 
intervention trial in 
middle-school girls 
from 6 states in the 
United States. 
Hispanic, non-
Hispanic black, and 
non-Hispanic White 
were only included.
Sample size : 918
Baseline age (y) : 11
Follow-up : 2 cycles 
over 2 years. 
Sex : Females
Measured 
H&W. 
Categorical 
(CDC 
reference- 
obese vs. not 
obese). 
Continuous 
(BMI z-
score).
CES-D 
(SR). 
Categorica
l  (scores ≥ 
24 = 
clinically 
significant 
depressive 
symptoms). 
Continuous 
(depressive 
symptoms).
Age, Time typically 
spent home alone after 
school, Lunch type 
(free/reduced), Race .
Baseline dependent 
variable . Controlled in 
analyses.Excluded in 
analyses.
Moderation analyses : 
Obesity X Race
Multivariate logistic 
regression . Unadjusted 
and adjusted ORs and 
95% CIs were calculated 
for obese status (obese vs. 
Not obese) at C1 on 
subsequent CSDS 2 years 
later. 
Multivariate linear 
regression  using 
depressive symptoms 
scores.
Moderation analyses : Sig 
(Race)
Not adjusted for baseline 
dependent variable. 
White: 2.48 (1.93, 3.19).
Black: 1.03 (0.46, 2.31). 
Hispanic: 0.86 (0.38, 1.94). 
Controlled baseline 
dependent variable.
White: 2.09 (1.44, 3.02). 
Black: 1.29 (0.57, 2.88). 
Hispanic: 0.76 (0.31, 1.85).
 
Excluded baseline 
dependent variable.  
White: 2.5 (1.57, 3.98). 
Black: 0.98 (0.16, 5.97). 
Hispanic: 0.72 (0.26, 1.95).
Results using continuous 
variables were consistent with 
results using dichotomous 
variables (results not shown).
Obesity status predicted 
subsequent clinically 
significant depressive 
symptoms (CSDS) only 
for White females, both 
before and after 
covariate adjustement, 
and both when baseline 
CSDS were controlled 
for or when females with 
baseline CSDS were 
excluded.
Analysis type Adjusted odds ratio (95% 
confidence interval) or other 
statistics reported
Unadjusted odds ratio (95% 
confidence interval) or other 
statistics reported
Observed relationship
Table 1.  Studies examining body mass as a predictor of depressive symptoms.
Body Mass 
measure
Sample 
Characteristics
CovariatesDepressive 
Symptoms 
measure
Author(s), 
Year
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Ball, 
Burton, & 
Brown, 
2009
Community-based 
study of young women 
in Australia. 
Sample size : 6677
Baseline age (y) : 22-
27
Follow-up : 2 cycles 
over 3 years.
Sex : Females
SR H&W. 
Categorical 
(WHO 
classifications- 
underweight, 
normal 
weight, 
overweight, 
obese).
CES-D-10 
(SR). 
Categorica
l  (scores ≥ 
10 = 
clinically 
significant 
depressive 
symptoms).
Education, Marital 
status, Occupation, 
Smoking status, Parity 
status, Serious health 
problems/disability, 
Physical activity . 
Excluded pregnant 
women.
Baseline dependent 
variable.  Controlled in 
analyses.
Multivariate logistic 
regression . Crude and 
adjusted ORs and 95% 
CIs were calculated for 
the influence of C1 weight 
status (underweight, 
overweight, obese, vs. 
normal weight) on 
subsequent CSDS.
All ORs not adjusted for 
baseline dependent 
variable . 
Underweight 1.26 (0.99,1.6): 
Overweight 1.32 (1.14, 
1.53); Obese 1.81 (1.50, 
2.18).
Underweight: 1.09 (0.83, 
1.42); Overweight: 1.21 
(1.03, 1.43); Obese: 1.33 
(1.08, 1.65).
Overweight and obese 
females, compared with 
normal weight females, 
had higher risk for 
clinically significant 
depressive symptoms at 
follow-up, both before 
and after covariate 
adjustment. NS for 
underweight females.
Boutelle, 
Hannan, 
Fulkerson, 
et al., 
2010
Community-based 
study of adolescents in 
metropolitan area of 
Austin, Texas.
Sample size : 496
Baseline age (y) : 
~13.5
Follow-up : 4 annual 
cycles
Sex : Females
Measured 
H&W. 
Categorical 
(CDC 
reference- 
not 
overweight, 
overweight, 
obese).
K-SADS 
(SR). 
Continuous 
(depressive 
symptoms).
Age, Early puberty 
status.
Baseline dependent 
variable. Controlled in 
analyses. Excluded in 
analyses. 
Linear regression. 
Adjusted coefficients with 
GEE to calculate influence 
of obesity status 
(overweight, obese, vs. 
not overweight) the 
previous year on 
depressive symptoms the 
subsequent year.
Not presented. Controlled baseline 
dependent variable.
Overweight: β = 0.0016 (SE 
= .03, p = .96);
 Obese: β = 
0.17 (SE = .05, p    .01).
Excluded baseline 
dependent variable.
Did not mention results.
Overweight status was 
not associated with 
subsequent depressive 
symptoms. Obese status 
was associated with 
subsequent higher 
depressive symptoms 
when compared to 
females who were not 
overweight.
Analysis type Adjusted odds ratio (95% 
confidence interval) or other 
statistics reported
Unadjusted odds ratio (95% 
confidence interval) or other 
statistics reported
Observed relationship
Table 1.  Studies examining body mass as a predictor of depressive symptoms (continued).
Body Mass 
measure
Sample 
Characteristics
CovariatesDepressive 
Symptoms 
measure
Author(s), 
Year
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Clark, 
Haines, 
Head, et 
al., 2007
Community-based 
sample of adolescents 
attending school in 
East London.
Sample size : 1513
Baseline age (y) : 11-
14
Follow-up : 2 cycles 
over 2 years
Sex:  Both
Measured 
H&W. 
Categorical 
(United 
Kingdom 
reference 
curve 
classifications- 
overweight: 
BMI > 95th 
percentile, 
obese: BMI 
> 85th 
percentile).
SMFQ 
(SR). 
Categorica
l  (scores ≥ 
8 = clinically 
significant 
depressive 
symptoms).
Age, Gender, Eligibility 
for free school meals, 
Ethnicity, General 
health status, Long-
standing illness, 
Smoking, Alcohol use, 
Drug use, Physical 
activity.
Baseline dependent 
variable. Controlled in 
analyses. Excluded in 
analyses. 
Moderation analyses :
Gender X Age
Multivariate logistic 
regression . Crude and 
adjusted ORs and 95% 
CIs were calculated for 
the influence of C1 weight 
status (overweight, obese, 
vs. not overweight) on 
subsequent CSDS.
Moderation analyses : 
NS (Gender)
Not adjusted for baseline 
dependent variable .
Overweight: 1.20 (0.95, 
1.53); Obese: 1.04 (0.80, 
1.36).
Controlled baseline 
dependent variable.
Overweight: 1.16 (0.90, 
1.50); Obese: 0.99 (0.75, 
1.30).
Excluded baseline 
dependent variable.
Similar results (not presented).
Neither overweight 
status nor obesity status 
predicted subsequent 
clinically significant 
depressive symptoms, 
either before or after 
covariate adjustement.
Analysis type Adjusted odds ratio (95% 
confidence interval) or other 
statistics reported
Unadjusted odds ratio (95% 
confidence interval) or other 
statistics reported
Observed relationship
Table 1.  Studies examining body mass as a predictor of depressive symptoms (continued).
Body Mass 
measure
Sample 
Characteristics
CovariatesDepressive 
Symptoms 
measure
Author(s), 
Year
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Goodman 
& 
Whitaker, 
2002
Nationally 
representative cohort 
of adolescents in the 
US.
Non-Hispanic White, 
non-Hispanic Black, 
and Hispanic were 
included only.
Sample size : 9374
Baseline age (y) : 12-
19
Follow-up : 2 cycles 
over 1 year
Sex : Both
SR H&W. 
Categorical 
(CDC 
reference- 
not obese, 
obese; for 
participants 
20 years and 
older at 
follow-up, 
obese: BMI 
≥ 30). 
Modified 
CES-D-18 
(SR). 
Categorica
l  (scores ≥ 
24 for 
females and 
≥ 22 for 
males = 
clinically 
significant 
depressive 
symptoms).
Level 1 covariates: Age, 
Gender, Race (White 
non-Hispanic/ Black 
non-Hispanic/ 
Hispanic), Parent 
education, Two parents 
in the home vs. Other. 
Level 2 covariates: Self-
esteem, Smoking, 
Delinquent behavior, 
Low physical activity.
Baseline dependent 
variable.  Controlled in 
analyses.
Moderation analyses :
Self-esteem X CSDS, 
Smoking X CSDS, 
Delinquent behavior X 
CSDS, Low physical 
activity X CSDS
Multivariate logistic 
regression . Unadjusted 
and adjusted ORs and 
95% CIs were calculated 
for obese status (obese vs. 
Not obese) at C1 on 
subsequent CSDS 1 year 
later. 
Moderation analyses : 
NS (All)
9.9% of those obese at C1 
had CSDS at follow-up, 
compared with 8.7 of those 
not obese at baseline (p = 
0.43). 
Level 1 covariates: 1.16 
(0.81, 1.65). 
Level 1 and 2 covariates: NS 
(results not reported).
Those who were obese 
at baseline did not have 
increased risk of 
clinically significant 
depressive symptoms at 
follow-up. 
Analysis type Adjusted odds ratio (95% 
confidence interval) or other 
statistics reported
Unadjusted odds ratio (95% 
confidence interval) or other 
statistics reported
Observed relationship
Table 1.  Studies examining body mass as a predictor of depressive symptoms (continued).
Body Mass 
measure
Sample 
Characteristics
CovariatesDepressive 
Symptoms 
measure
Author(s), 
Year
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Herva, 
Laitinen, 
Miettunen, 
et al., 
2006
Community-based 
study of adolescents in 
two provinces of 
Finland (all 
Caucasian).
Sample size:  8451
Baseline age (y) : 14
Follow-up : 2 cycles 
over 17 years
Sex : Both
SR H&W. 
Categorical 
(internal 
references- 
overweight: 
85th-95th 
percentile, 
obese:  BMI 
≥ 95th 
percentile)
HSCL. 
Categorica
l  (three 
different 
score cut-
offs used = 
1.55, 1.75, 
2.01).
Father`s social class, 
Family type, Chronic 
somatic disease, 
Smoking, Alcohol use. 
Baseline dependent 
variable. Did not control 
for or exclude in analyses.
Multivariate logistic 
regression . Crude and 
adjusted ORs and 95% 
CIs were calculated for 
the influence of C1 weight 
status (overweight, obese, 
vs. not overweight) on 
subsequent CSDS status.
Moderation analyses : 
Stratified by gender.
All HSCL cut-offs for 
overweight : NS. 
HSCL cut-off of 1.55. 
Males: obese 1.15 (0.79, 
1.69). 
Females: obese 1.34 (0.98, 
1.82). 
HSCL cut-off of 1.75. 
Males: obese 1.26 (0.80, 
1.96). 
Females: obese 1.63 (1.16, 
2.29). 
HSCL cut-off of 2.01. 
Males: obese 1.94 (1.07, 
3.52). 
Females: obese 1.49 (0.89, 
2.47).
All HSCL cut-offs for 
overweight: NS. 
HSCL cut-off of 1.55. 
Males: obese 1.08 (0.72, 
1.61). 
Females: obese 1.33 (0.97, 
1.83). 
HSCL cutoff of 1.75. 
Males: obese 1.18 (0.73, 
1.89). 
Females: obese 1.64 (1.16, 
2.32). 
HSCL cutoff of 2.01. 
Males: obese 1.97 (1.06, 
3.68). 
Females: obese 1.55 (0.93, 
2.59).
Overweight status at age 
14 did not predict 
subsequent clinically 
significant depressive 
symptoms (CSDS) at 
any cut-off point. When 
using a HSCL cut-off of 
1.75, obese females at 
age 14 had higher risk 
of CSDS at 31, 
compared with not 
overweight females. 
When using a HSCL 
cutoff of 2.01, males 
with obesity at 14 had 
higher risk of CSDS at 
31, compared with not 
overweight males.
Analysis type Adjusted odds ratio (95% 
confidence interval) or other 
statistics reported
Unadjusted odds ratio (95% 
confidence interval) or other 
statistics reported
Observed relationship
Table 1.  Studies examining body mass as a predictor of depressive symptoms (continued).
Body Mass 
measure
Sample 
Characteristics
CovariatesDepressive 
Symptoms 
measure
Author(s), 
Year
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Merten, 
Wickrama, 
& 
Williams, 
2008
Nationally 
representative cohort 
of US adolescents.
Sample size : 7881
Baseline age (y) : 12-
18
Follow-up : 2 cycles 
over 6 years
Sex : Both
SR H&W. 
Categorical 
(CDC 
reference- 
not obese, 
obese).
CES-D-9 
(SR). 
Continuous 
(depressive 
symptoms).
Parental education, 
Family economic 
hardship, Young adult 
status attainment, Race.
Baseline dependent 
variable.  Controlled in 
analyses.
Moderation analyses :
Gender X Obesity, 
Obesity X Race
Multivariate linear 
regression . Adjusted 
coefficients to estimate 
influence of obesity status 
(obese vs. not obese) in 
adolescence on 
subsequent depressive 
symptoms in young 
adulthood.
Moderation analyses : 
Sig. (Gender), NS (Race)
N/A Females.
β = 0.03, SE = 0.19, p  < 
.001. 
Males.
β = 0.01, SE = 0.14, NS.
Among females, obesity 
in adolescence was 
associated with higher 
depressive symptoms in 
young adulthood. No 
significant associations 
between obesity and 
depressive symptoms 
for males.
Rhew, 
Richardso
n, Lymp, 
et al., 
2008
Community-based 
study of sixth grade 
students from public 
middle schools in 
Seattle, Washington.
Oversampled students 
scoring high on 
depression or 
disruptive behavior.
Sample size : 446
Baseline age (y) : ~12
Follow-up : 2 cycles 
over 1 year
Sex:  Both
SR H&W. 
Measured 
H&W 
(n=165). 
Categorical 
(CDC 
reference- 
not 
overweight, 
overweight, 
obese). 
MFQ (SR). 
Continuous 
(depressive 
symptoms- 
log 
transformed)
.
Gender, Household 
income, Education of 
primary caregiver, 
Physical development, 
Race (Black, Pacific 
Islander, Other).
Baseline dependent 
variable.  Controlled in 
analyses.
Moderation analyses :
Depression X Gender
Multivariate linear 
regression . Unadjusted 
and adjusted ORs and 
95% CIs were calculated 
for overweight status 
(overweight vs. Not 
overweight and obese vs. 
not overweight) at C1 on 
subsequent depressive 
symptoms 1 year later.
Moderation analyses : 
NS (Gender) 
N/A. Self-report BMI .
β= -0.08, p = 0.52.
Measured BMI .
Similar results. 
Similar results when using a 
obese instead of overweight.
Neither overweight 
status nor obese status 
at baseline predicted 
subsequent depressive 
symptoms 1 year later, 
regardless of whether 
BMI was self-reported 
or measured. 
Analysis type Adjusted odds ratio (95% 
confidence interval) or other 
statistics reported
Unadjusted odds ratio (95% 
confidence interval) or other 
statistics reported
Observed relationship
Table 1.  Studies examining body mass as a predictor of depressive symptoms (continued).
Body Mass 
measure
Sample 
Characteristics
CovariatesDepressive 
Symptoms 
measure
Author(s), 
Year
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Xie, 
Unger, 
Gallaher, 
et al., 
2010
Community sample of 
middle school students 
in Los Angeles 
(Asians and Hispanics 
only).
Data came from 
smoking prevention 
trial study.
Sample size : 1155
Baseline age (y) : 12
Follow-up : 2 cycles 
over 1 year
Sex : Both
Measured 
H&W. 
Categorical 
(CDC 
reference- 
overweight, 
not 
overweight).
CES-D-5 
(SR). 
Continuous 
(depressive 
symptoms).
Pubertal status, SES, 
Smoking status, Age, 
Ethnicity, Intervention 
group.
Baseline dependent 
variable.  Controlled in 
analyses.
Moderation analyses :
Gender X Overweight, 
Race X Overweight, 
Acculturation X 
Overweight
Multivariate linear 
regression. Multiple 
group SEMs to compare 
associations of overweight 
status (vs. not overweight 
status) on subsequent 
depressive symptoms; 
separately for males and 
females, Asians and 
Hispanics, and accultured 
and not accultured.
Moderation analyses : 
Sig. (Gender, Race, 
Acculturation)
N/A Standardized (unstandardized) 
parameter estimates. 
Girl, Low AC: 0.13 (0.07, 
NS). 
Girl, High AC: -0.14 (-0.07, 
NS). 
Boy, Low AC: 0.22 (0.14, p 
< .05). 
Boy, High AC: 0.06 (0.04, 
NS). 
Girl, Asian: -0.26 (-0.09, 
NS). 
Girl, Hispanic: 0.01 (0.01, 
NS). 
Boy, Asian: 0.26 (0.15, p < 
.05). 
Boy, Hispanic: 0.12 (0.11, 
NS)
Asian males who were 
overweight at baseline 
had higher depressive 
symptoms at follow-up 
than non-overweight 
Asian males. Boys with 
low acculturation who 
were overweight at 
baseline had higher 
subsequent depressive 
symptoms compared to 
their not overweight 
counterparts. No other 
significant associations.
SR: self-reported. H&W: height and weight. Sig: significant. AC: Accultured. OR: odds ratio. CI: Confidence interval. CSDS: Clinically significant depressive symptoms. SES: socioeconomic status. NS: not 
significant. N/A: not applicable or not analyzed. CDC: Center for Disease Control. BMI: body mass index. WHO: World Health Organization. CES-D: Center for Epidemiological Studies- Depression 
Scale.  MFQ: Mood and Feeling Questionnaire. SMFQ: Short Mood and Feeling Questionnaire. HSCL = Hopkins Symptom Checklist-25. SE: standard error. K-SADS: Schedule for Affective Disorders 
and Schizophrenia for School-Age Children. GEE: generalized estimating equations. SEM: structural equation model.
Analysis type Adjusted odds ratio (95% 
confidence interval) or other 
statistics reported
Unadjusted odds ratio (95% 
confidence interval) or other 
statistics reported
Observed relationship
CDC classifications: Obesity= greater than or equal to 95th percentile; Overweight = 85th percentile; Not overweight = <85th percentile.
WHO classifications: Obesity = BMI≥30; Overweight = BMI 25-29.99; Normal weight = BMI 18.50-24.99; Underweight = BMI<18.5
Table 1.  Studies examining body mass as a predictor of depressive symptoms (continued).
Body Mass 
measure
Sample 
Characteristics
CovariatesDepressive 
Symptoms 
measure
Author(s), 
Year
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Table 2 . Studies examining depressive symptoms as a predictor of body mass.
Anderson, 
Murray, Johnson, 
et al., 2011
Random sample 
from multi-center 
group-randomized 
intervention trial in 
middle-school girls 
from 6 states in the 
US. 
Hispanic, non-
Hispanic black, and 
non-Hispanic White 
were only included.
Sample size : 918
Baseline age (y) : 
11
Follow-up : 2 
cycles over 2 years. 
Sex : Females
Measured 
H&W. 
Categorical 
(CDC 
reference- 
obese vs. not 
obese). 
Continuous 
(BMI z-
score).
CES-D (SR). 
Categorical 
(scores ≥ 24 = 
clinically 
significant 
depressive 
symptoms). 
Continuous 
(depressive 
symptoms).
Age, Time typically spent 
home alone after school, 
Lunch type (free/reduced), 
Race .
Baseline dependent 
variable . Controlled in 
analyses. Excluded in 
analyses.
Moderation analyses : 
Obesity X Race
Multivariate logistic 
regression . Unadjusted 
and adjusted ORs and 
95% CIs were calculated 
for CSDS status at C1 on  
subsequent obesity status 
2 years later.
Multivariate linear 
regression  using BMI. 
Moderation analyses : 
Sig (Race)
Not 
adjusted for 
baseline 
dependent 
variable. 
White: 4.13 
(1.77, 9.64). 
Black: 0.82 
(0.40, 1.67). 
Hispanic: 
1.66 (0.58, 
4.73)
Controlled baseline 
dependent variable.
White: 3.68 (1.72, 7.87). 
Black: 1.58 (0.65, 3.83). 
Hispanic: 1.64 (0.36, 7.49).
Excluded baseline 
dependent variable. 
White: 3.11 (0.85, 11.32). 
Black: 1.56 (0.51, 4.72). 
Hispanic: 1.34 (0.12, 
14.81).
Results using continuous 
variables were consistent 
with results using 
dichotomous variables 
(results not shown).
Depression predicted 
subsequent obesity status only 
in White females, in both 
unadjusted and adjusted 
models, controlling for 
baseline obesity. In adjusted 
models that excluded females 
with baseline obesity status, 
depression did not predict 
subsequent obesity onset for 
any race. 
Bardone, Moffitt, 
Caspi, et al., 
1998
Cohort of 
adolescents from 
New Zealand.
Sample size : 459
Baseline age (y) : 
15
Follow-up : 2 
cycles over 6 years
Sex : Females
Measured 
H&W. 
Continuous 
(BMI).
DISC 
(Interview). 
Categorical 
(diagnosis of 
MDD or 
dysthymia = 
depression)
SES, Age at menarche, 
Absence of a father figure, 
Parental smoking, 
Childhood health, 
Maternal health, Maternal 
BMI, Religiosity, Daughter 
of teenage mother.
Baseline dependent 
variable. Did not control for 
or exclude in analyses.
Multivariate linear 
regression . Unadjusted 
and adjusted coefficients 
to estimate influence of 
depression (depressed vs. 
Not depressed) at age 15 
on subsequent BMI at 
age 21.
β = 0.06 
(NS)
β = 0.05 (NS) Depression at age 15 did not 
predict BMI at age 21, both 
before and after covariate 
adjustment.
CovariatesAuthor(s), Year Sample 
Characteristics
Body mass 
measure
Depressive 
symptoms 
measure
Observed relationshipAnalysis type Unadjusted 
result
Adjusted odds ratio (95% 
confidence interval) or other 
statistics reported
 
  
114
Table 2 . Studies examining depressive symptoms as a predictor of body mass (continued).
Barefoot, 
Heitmann, Heims, 
et al., 1998
Cohort of University 
of North Carolina 
students.
Sample size : 4673
Baseline age (y) : 
16-25
Follow-up : 2 
cycles over 23 years 
Sex:  Both
Measured 
H&W  at 
baseline. SR 
H&W at 
follow-up. 
Continuous 
(change in 
BMI).
MMPI ODS 
(SR). 
Categorical 
(scores ≥ 13 for 
females and ≥ 
11 for males = 
clinically 
significant 
depressive 
symptoms). 
Continuous 
(depressive 
symptoms).
Gender, Exercise, 
Smoking. 
Baseline dependent 
variable. Controlled in 
analyses. 
Moderation analyses :
Gender X BMI, BMI X 
CSDS 
Multivariate linear 
regression . Adjusted 
coefficients to estimate 
influence of CSDS status  
on BMI change between 
two cycles.
Moderation analyses : 
Sig (All)
N/A β = -19.68, p < 0.001. Participants with clinically 
significant depressive 
symptoms who were initially 
lean gained less weight than 
lean participants who without 
clinically significant depresive 
symptoms. 
Participants with clinically 
significant depressive 
symptoms who were intitially 
heavy appear to have gained 
more weight than heavy 
participants without clinically 
significant depressive 
symptoms. 
CovariatesAuthor(s), Year Sample 
Characteristics
Body mass 
measure
Depressive 
symptoms 
measure
Observed relationshipAnalysis type Unadjusted 
result
Adjusted odds ratio (95% 
confidence interval) or other 
statistics reported
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Table 2 . Studies examining depressive symptoms as a predictor of body mass (continued).
Duarte, 
Sourander, 
Nikolakaros, et 
al., 2010
National population-
based cohort of 
children born in 
Finland in 1981.
Sample size : 2209
Baseline age (y) : 8
Follow-up : 2 
cycles over 10-15 
years
Sex : Males
Measured 
H&W. 
Categorical 
(WHO 
classification- 
normal 
weight, 
overweight, 
obese)
CDI (SR). 
Categorical 
(internal 
reference- < 
50th percentile = 
no CSDS, 50th-
90th percentile = 
moderate 
CSDS, > 90th 
percentile = 
severe CSDS. 
Continuous 
(number of 
symptoms).
Mother's education, Age at 
follow-up. 
Baseline dependent 
variable. Did not control for 
or exclude in analyses.
Excluded underweight.
Multivariate logistic 
regression . Adjusted 
ORs and 95% CIs were 
calculated for the 
influence of childhood 
CSDS status  on 
subsequent weight status 
(obese, overweight).
N/A Categorical depressive 
symptoms. 
Moderate CSDS → 
overweight: 1.3 (1.01, 
1.7). 
Moderate CSDS → 
obesity: 1.0 (0.6, 1.6). 
Severe CSDS → 
overweight: 1.2 (0.8, 1.8). 
Severe CSDS → obesity: 
0.6 (0.2, 1.4).
Continuous depressive 
symptoms .
Overweight: 1.1 (0.98, 
1.2);
Obese: 0.9 (0.7, 1.2)
Children with moderate 
clinically significant depressive 
symptoms (CSDS) at age 8 
were more likely to be 
overweight in young 
adulthood compared to 
children without CSDS after 
covariate adjustement. 
Nothing significant for 
moderate CSDS predicting 
obesity, or severe CSDS 
predicting overweight/obesity.
With continuous depressive 
symptoms, depressive 
symtpoms at age 8 years were 
not associated with being 
overweight or obese.
CovariatesAuthor(s), Year Sample 
Characteristics
Body mass 
measure
Depressive 
symptoms 
measure
Observed relationshipAnalysis type Unadjusted 
result
Adjusted odds ratio (95% 
confidence interval) or other 
statistics reported
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Table 2 . Studies examining depressive symptoms as a predictor of body mass (continued).
Franko, Striegel-
Moore, 
Thompson, et al., 
2005
Two community-
based cohorts of 
Black and White 
girls in 3 US states 
(California, 
Maryland, Ohio).
Sample size : 1554
Baseline age (y) :  
~16.5
Follow-up : 3 
cycles at ages 16, 
18, and 21
Sex : Females
SR H&W at 
C1, C2. 
Measured 
H&W at C3. 
Categorical 
(CDC 
reference- 
not obese,  
obese; for 
participants 
21 years and 
older at 
follow-up, 
obese = 
BMI ≥ 30). 
Continuous 
(BMI).
CES-D (SR). 
Continuous 
(depressive 
symptoms).
Race (Black/ White), Site 
(Ohio/  Maryland/ 
California), Parental 
education.
Baseline dependent 
variable . Controlled in 
analyses.
Moderation analyses :
Race X Depressive 
symptoms
Multivariate linear 
regression . Adjusted 
coefficients to estimate 
influence of depressive 
symptoms at age 16 and 
18 (separate models) on 
subsequent BMI at age 
21.
Multivariate logistic 
regression.  Adjusted 
ORs and 95% CIs  
calculated for the 
influence of depressive 
symptoms at age 16 and 
18 (separate models) on 
subsequent obesity at age 
21.
N/A Multivariate linear 
regression. 
Depressive Symptoms at 
age 16: β = 0.03 (SE = 
.009, p = .002).
Depressive Symptoms at 
age 18: β=0.02 (SE = 
.008, p = 0.01). 
Multivariate logistic 
regression. 
Depressive Symptoms at 
age 16: 3.11 (1.13, 5.12).
Depressive Symptoms at 
age 18: 3.50 (1.26, 5.80). 
Higher depressive symptoms 
at age 16 or 18 predicted 
increased risk of obesity at 
age 21, after covariate 
adjustment. Same pattern 
when BMI was continuous.
CovariatesAuthor(s), Year Sample 
Characteristics
Body mass 
measure
Depressive 
symptoms 
measure
Observed relationshipAnalysis type Unadjusted 
result
Adjusted odds ratio (95% 
confidence interval) or other 
statistics reported
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Table 2 . Studies examining depressive symptoms as a predictor of body mass (continued).
Goodman & 
Whitaker, 2002
Nationally 
representative 
cohort of 
adolescents in the 
US.
Non-Hispanic 
White, non-Hispanic 
Black, and Hispanic 
were included only.
Sample size : 9374
Baseline age (y) : 
12-19
Follow-up : 2 
cycles over 1 year
Sex : Both
SR H&W. 
Categorical 
(CDC 
reference- 
not obese, 
obese; for 
participants 
20 years and 
older at 
follow-up, 
obese: BMI 
≥ 30). 
Modified CES-
D-18 (SR). 
Categorical 
(scores ≥ 24 for 
females and ≥ 
22 for males = 
clinically 
significant 
depressive 
symptoms).
Level 1 covariates: Age, 
Gender, Race (White non-
Hispanic/ Black non-
Hispanic/ Hispanic), 
Parental obesity, Parent 
education, Two parents in 
the home vs. Other.
Level 2 covariates: Self-
esteem, Smoking, 
Delinquent behavior, Low 
physical activity.
Baseline dependent 
variable . Controlled BMI z-
score in analyses. Excluded 
obese in analyses.
Moderation analyses :
Gender, Self-esteem X 
CSDS, Smoking X CSDS, 
Delinquent behavior X 
CSDS, Low physical activity 
X CSDS
Multivariate logistic 
regression . Unadjusted 
and adjusted ORs and 
95% CIs were calculated 
for clinically significant 
depressive symptoms at 
C1 on subsequent obesity 
status 1 year later. 
Moderation analyses : 
Sig (Smoking), NS (All 
else)
12.4% of 
those with 
CSDS at C1 
were obese 
at follow-up, 
compared 
with 9.4% of 
those without 
CSDS at 
baseline (p = 
.048).
Level 1 covariates. 
Controlled for baseline 
BMI z-score: 2.05 (1.18, 
3.56). 
Excluded obese at 
baseline: 2.05 (1.04, 
4.06). 
Level 1 and 2 covariates. 
Controlled for baseline BMI 
z-score: did not present 
results. 
Excluded obese at 
baseline: 2.39 (1.05, 
5.45).
Those with clinically significant 
depressive symptoms (CSDS) 
at baseline had a higher risk of 
obesity at follow-up, 
compared to those without 
CSDS at baseline. Similar 
magnitude of effect between 
analyses that excluded obese 
at baseline and analyses that 
controlled for baseline BMI z-
score.
Those with CSDS who 
smoked heavily were at an 
increased risk for worsening 
obesity, compared to those 
who did not smoke.
CovariatesAuthor(s), Year Sample 
Characteristics
Body mass 
measure
Depressive 
symptoms 
measure
Observed relationshipAnalysis type Unadjusted 
result
Adjusted odds ratio (95% 
confidence interval) or other 
statistics reported
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Table 2 . Studies examining depressive symptoms as a predictor of body mass (continued).
Goodwin, 
Sourander, 
Duarte, et al., 
2009
National population-
based cohort of 
children born in 
Finland in 1981.
Sample size: 2712
Baseline age (y): 8
Follow-up: 3 cycles 
over 10-15 years
Sex: Males
Measured 
H&W. 
Categorical 
(physician 
diagnosis of 
obesity using 
ICD-10 
criteria).
CDI (SR). 
Categorical 
(internal 
reference- < 
50th percentile = 
no CSDS, 50th-
90th percentile = 
moderate 
CSDS, > 90th 
percentile = 
severe CSDS. 
Continuous 
(number of 
symptoms).
Mother's education, 
Somatic health problems at 
age 8.
Baseline dependent 
variable. Did not control for 
or exclude in analyses.
Multivariate logistic 
regression . Unadjusted 
and adjusted ORs and 
95% CIs were calculated 
for the influence of 
childhood CSDS status 
on subsequent obesity in 
young adulthood.
Moderate 
CSDS: 1.4 
(0.9, 2.3). 
Severe 
CSDS: 0.7 
(0.3, 1.8).
Moderate CSDS: 1.4 (0.9, 
2.3). 
Severe CSDS: 0.5 (0.2, 
1.4).
CSDS in childhood did not 
predict increased risk of 
obesity in young adulthood, 
both before and after 
covariate adjustment. Similar 
results with continuous 
depressive symptoms.
Jansen, van de 
Looij-Jansen, de 
Wilde, et al., 
2008
Community-based 
study of youth in 
Rotterdam 
(Netherlands).
Sample size : 787
Baseline age (y) : 9-
10
Follow-up : 2 
cycles over 3 years
Sex : Both
Measured 
H&W at C1, 
SR H&W at 
C2. 
Categorical 
(WHO 
classifications- 
not 
overweight, 
overweight, 
obese). 
SDQC (SR). 
Categorical 
(score ≥ 4 = 
clinically 
significant 
depressive 
symptoms).
Gender, Country of origin, 
Level of education.
Baseline dependent 
variable . Controlled in 
analyses.
Moderation analyses : 
Gender X Weight Status
Multivariate logistic 
regression . Adjusted 
ORs and 95% CIs were 
calculated for the 
influence of childhood 
CSDS on subsequent 
weight status (obese, 
overweight).
Moderation analyses : 
NS (Gender)
N/A Did not present results. Clinically significant 
depressive symptoms at C1 
did not predict weight status 3 
years later, after covariate 
adjustment.
CovariatesAuthor(s), Year Sample 
Characteristics
Body mass 
measure
Depressive 
symptoms 
measure
Observed relationshipAnalysis type Unadjusted 
result
Adjusted odds ratio (95% 
confidence interval) or other 
statistics reported
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Table 2 . Studies examining depressive symptoms as a predictor of body mass (continued).
Pine, Cohen, 
Brook, et al., 
1997
Community-based 
study of an 
adolescent cohort in 
upstate New York.
Sample size : 644
Baseline age (y) : 9-
18
Follow-up : 2 
cycles over 9 years
Sex : Both
SR H&W. 
Categorical 
(internal 
reference- 
obesity = 
BMI > 80th 
percentile). 
Continuous 
(BMI).
DISC (from 
either mother or 
child report at 
C1, from child 
only at C2). 
Continuous 
(depressive 
symptoms).
Age, Ethnicity, Parental 
social class, Parental 
sociopathy, Physical health 
status, Childhood IQ, 
Smoking and alcohol use.
Baseline dependent 
variable. Did not control for 
or exclude in analyses.
Multivariate linear 
regression . Unadjusted 
and adjusted coefficients 
to estimate influence of 
depressive symptoms 
during adolecence on 
subsequent BMI in young 
adulthood. 
Multivariate logistic 
regression.  Adjusted 
ORs and 95% CIs  
calculated for the 
influence of depressive 
symptoms during 
adolecence on subsequent 
BMI in young adulthood.
Categorical. 
Males: 1.46 
(0.78, 2.74).
Females: 
3.06 (1.91, 
4.91). 
Continuous . 
Not 
presented.
Categorical. 
Not presented. 
Continuous.
β = 0.38 ± .19 (p < .05). 
When conduct disorder 
entered into model: β = 
0.15  ± .20 (NS).
Before covariate adjustment, 
depressive symptoms during 
adolescence predicted young 
adult obesity in females, but 
not males. In multivariate 
associations, depressive 
symptoms during adolescence 
predicted young adult BMI 
only when adolescent conduct 
disorder was not included in 
the model (males and females 
grouped together).
Rhew, 
Richardson, 
Lymp, et al., 
2008
Community-based 
study of sixth grade 
students from public 
middle schools in 
Seattle, Washington.
Oversampled 
students scoring high 
on depression or 
disruptive behavior.
Sample size : 446
Baseline age (y) : 
~12
Follow-up : 2 
cycles over 1 year
Sex:  Both
SR H&W. 
Measured 
H&W. 
Continuous 
(BMI).
MFQ (SR). 
Categorical 
(scores ≥ 15 = 
clinically 
significant 
depressive 
symptoms).
Gender, Household 
income, Education of 
primary caregiver, 
Physical development, 
Race (Black, Pacific 
Islander, Other).
Baseline dependent 
variable.  Controlled in 
analyses.
Moderation analyses :
Depression X Gender
Multivariate linear 
regression . Unadjusted 
and adjusted ORs and 
95% CIs were calculated 
for CSDS at C1 on 
subsequent BMI 1 year 
later. 
Moderation analyses : 
Sig (Gender)
Self-report 
BMI. Males -
0.48 (-1.64, 
0.67). 
Females: 
3.16 (1.91, 
4.40). 
Measured 
BMI. Results 
not reported.
Self-report BMI. 
Males: β= -1.18 (-1.99, -
0.37).
Females: β= 2.49 (1.44, 
3.54). 
Measured BMI. 
Males: β = 0.12 (-0.49, 
0.73). 
Females: β = 0.54 (-0.42, 
1.51). 
For self-reported BMI, males 
with clinically significant 
depressive symptoms (CSDS) 
at baseline had lower 
subsequent BMI compared to 
males without CSDS, after 
covariate adjustement 
(although this association was 
not significant before 
adjustment). For females, 
CSDS at baseline predicted 
higher BMI, both before and 
after covariate adjustment (for 
self-reported BMI). When 
BMI was measured, 
depression did not predict 
subsequent BMI levels.
CovariatesAuthor(s), Year Sample 
Characteristics
Body mass 
measure
Depressive 
symptoms 
measure
Observed relationshipAnalysis type Unadjusted 
result
Adjusted odds ratio (95% 
confidence interval) or other 
statistics reported
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Table 2 . Studies examining depressive symptoms as a predictor of body mass (continued).
Stice, Presnell, 
Shaw, et al., 
2005
Community-based 
cohort of adolescent 
girls from 4 public 
and 4 private 
schools in a 
metropolitan area of 
the southwestern 
US.
Sample size : 496
Baseline age (y) : 
11-15
Follow-up : 5 
annual cycles
Sex : Females
Measured 
H&W. 
Categorical 
(CDC 
classification- 
obesity).
SADS (SR). 
Continuous 
(depressive 
symptom 
severity index).
Dietary restraint, 
Compensatory behaviors, 
Perceived parental obesity
Baseline dependent 
variable. Excluded at 
baseline.
Multivariate logistic 
regression . Unadjusted 
and adjusted ORs and 
95% CIs were calculated 
for depressive symptoms 
at C1 on subsequent 
obesity over the 4-year 
follow-up period. 
4.62 (1.67, 
12.74)
2.32 (0.62, 8.65) After covariate adjustment, 
depressive symptoms at C1 
did not predict obesity onset 
during 4-year follow-up 
(associations were significant 
before adjustment).
CovariatesAuthor(s), Year Sample 
Characteristics
Body mass 
measure
Depressive 
symptoms 
measure
Observed relationshipAnalysis type Unadjusted 
result
Adjusted odds ratio (95% 
confidence interval) or other 
statistics reported
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Table 2 . Studies examining depressive symptoms as a predictor of body mass (continued).
Tanofsky-Kraff, 
Cohen, Yanovski, 
et al., 2006
Cohort of Black and 
White children from 
3 Maryland schools, 
US, at increased 
risk for adult 
obesity.
Sample size: 134
Baseline age (y): 6-
12
Follow-up: ~4 
annual cycles 
(follow-up periods 
ranged from 0.1-7.9 
years
Sex: Both
Measured 
DEXA. 
Continuous 
(fat mass, 
change in fat 
mass).
CDI (SR). 
Continuous 
(depressive 
symptoms).
Age at baseline, Gender, 
Race, SES, Pubertal stage, 
Time, Self-reported dieting, 
Binge eating, ChEAT total 
score.
Baseline dependent 
variable . Controlled in 
analyses.
Moderation analyses :
Gender X Race, Gender X 
Time
Linear regression. 
Mixed model with 
depression as fixed effect 
and child as random 
effect. Mixed regression 
model for predicting 
influence of depression at  
childhood on increase in 
body fat over course of 
follow-up.  
Moderation analyses: NS 
(All)
N/A β = 0.004, SE = 0.005 (-
0.007, 0.014), p  = .45
Depressive symptoms at 
baseline did not predict 
increases in body fat mass 
over time, after covariate 
adjustment. 
CDC classifications: Obesity= 95th percentile; Overweight = 85th percentile; Not overweight = <85th percentile.
WHO classifications: Obesity = BMI≥30; Overweight = BMI≥25; Normal weight = BMI 18.50-24.99; Underweight = BMI<18.5
CDI categories: scores <50th percentile = no depression, 50-90th percentile = moderate depression, ≥90th percentile = severe depression
Covariates
SR: self-reported. H&W: height and weight. C1, C2, etc.,: cycle 1, cycle 2, etc., respectively. N/A: not applicable or not analyzed. SES: socioeconomic status. Sig: significant. NS: not significant. CSDS: 
Clinically significant depressive symptoms. OR: odds ratio. CI: confidence interval. IQ: intelligence quotient. CDC: Center for Disease Control. BMI: body mass index. DISC: Diagnostic Interview Schedule 
for Children. MDD: major depressive disorder. WHO: World Health Organization. CES-D: Center for Epidemiological Studies- Depression Scale. MMPI-ODS Minnesota Multiphasic Inventory- Obvious 
Depression subscale. CDI: Children’s Depression Inventory. ICD-10: International Classification of Diseases-10. SADS: Schedule for Affective Disorders and Schizophrenia. DEXA: Dual-energy X-ray 
absorpitiometry. MFQ: Mood and Feelings Questionnaire. SDQC: Short Depression Questionnaire for Children.
Author(s), Year Sample 
Characteristics
Body mass 
measure
Depressive 
symptoms 
measure
Observed relationshipAnalysis type Unadjusted 
result
Adjusted odds ratio (95% 
confidence interval) or other 
statistics reported
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